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   INTRODUCTION 
 
 
  “capu;f;FWjp vy;yhk; clk;gpd; gaNd 
maph;g;gpd;wp Mjpia ehL.” 
- xsitf;Fws; 
 
“clk;ghu; mopapy; capuhu; moptu; 
 
 jplk;gl nka;Qhdk; NruTk; khl;lhu; 
 
 clk;ig tsu;f;Fk; cghak; mwpe;Nj 
 
 clk;ig tsu;j;Njd; capH tsu;j;NjNd”  
 
          -jpU%yu; 
 
This Quotations given above  stress the importance of maintaining a healthy body. 
Thirumoolar says that when one’s health deteriorates, the life force also deteriorates, 
preventing  the person from attaining divine wisdom. He also says that by knowing 
the techniques of protecting the body from deterioration one can preserve his body 
and extend his life time. 
 
 This reminds us of the famous saying  
  “Health is wealth” 
A healthy body is the real wealth of a person. Health is defined as a state of complete  
physical, mental and social wellbeing and not merely an absence of disease or 
infirminity. 
 
 According to Siddha System of Medicine , the treatment is given not only to 
the body but also to the mind. Physiolgical and psychological changes are said to be 
the causes for a disease and so the saying “A Sound mind in a sound body”  is very 
meaningful. 
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Siddhars have explained the basic functions and constituents of the body in a beautiful 
way. All the things including man are made up of five basic elements (Pancha 
Boothas) -Earth, Water, Fire, Air, and Space. 
 
 
 “Uyir thaathukkal” or humours namely Vatham, Pitham and Kabam are formed 
by the combination of these pancha boothas. Any derangement in these thathus will 
result in disease. 
 
 
“kpfpDk; FiwapDk; Neha;nra;Ak; EhNyhu; 
 tspKjyh vz;zpa %d;W.’ 
 
 
Food habits and daily activities of an individual play a major role in causing disease 
because the abnormal physical activities may disturb the levels of the three basic 
humours leading to disease. Emotion and stress also influence the Uyir thaathukkal  
ending up in a disease. 
 
 
Siddhars have classified diseases into 4448 types. In this modern mechanical world, 
people are suffering from various diseases. Females form the majority of  sufferers 
owing to their dual role both in family and in the society. 
 
 
In this dissertation the author speaks about Kumbavatham which is one among the  
80 types of Vaatham described by Yugi and it mimics most of the features of Cervical 
spondylosis. 
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AIM AND OBJECTIVES 
 
 
 
Kumbavatham is one of the Vaatha diseases with most of the signs and symptoms 
comparable to Cervical spondylosis. It is a painful and a distressing one involving 
shoulder girdle and upper limbs. It affects the people  in their active period of life and 
causes embarrassment both physically and mentally. The clinical study of 
Kumbavatham was done in 20 cases admitted and treated in inpatient ward and 20 
cases in outpatient Department of Sirappu Maruthuvam at Ayothidoss Pandithar 
Hospital of National Institute of Siddha, Chennai - 47. 
 
 
  
i) The author has attempted to study in this clinical trial the action of 
Vithurasa Mezhugu as internal medicine(Reference: Anuboga Vaithiya 
Navaneetham part - 5) and Vaatha Ennai as external medicine (Reference: 
Theraiyar Vaagadam) 
 
ii) The author has explained the clinical course of Kumbavatham and its 
various aspects such as aetiology, signs, sympotoms, pathology and 
complications on the basis of both Siddha and Modern Science. 
 
 
iii) The author has attempted to do a complete study of this disease under the 
following topics:  
    Mukkutra verupadugal     -       Imbalance or abnormalities of three thodams. 
Udal Thaathukkal             -       Seven physical constituents 
Poriyaal arithal                 -       Examination by sense organs 
Ennvagai thervugal           -       Eight types of examination 
 
iv) To observe the incidence of the disease in relation to age, sex, occupation, 
food and other habits and paruvakaalam(season). 
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v)        To evaluate the drugs by Qualitative, Pharmacological and Toxicological 
analysis. 
 
vi)       To use modern parameters to confirm the diagnosis and to assess the 
prognosis of the disease. 
 
vii)       Finally to produce an awareness among the patients about the preventive 
measures to avoid recurrence and complications of the disease.                                                                      
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KUMBA VATHAM 
 
DEFINITION  
 
Kumbavatham is one of the varieties of Vaatha diseases. It is a condition 
involving the Shoulder, presenting with the symptoms of pain in the Shoulder, 
radiating pain in the upper limbs, especially arms, burning sensation, tingling 
sensation in the eyes and cheeks, giddiness, pain below the umbilicus, burning 
sensation in the tongue. 
- Yugi Vaidhya Chinthaamani – 800 
 
DESCRIPTION OF THE NOMENCLATURE 
 
Kumbavatham - Kumbam + Vatham 
Kumbam - The upper portion of the Shoulder,  
  Scapula or Shoulder blade 
Vatham - One of the three humours 
 
AETIOLOGY 
 
The common aetiological factors for all types of Vaatha diseases including 
Kumbavatham have been described generally in Yugi Vaidhya Chinthaamani – 800 
and Agasthiyar Gunavaagadam. 
 
1. In Yugi Vaidhya Chinthaamani, the following causes have been given. 
Äkioee<x!gsh<OhiM!Kui<h<!Hjxh<H!
sikglib<!lqR<SgqZl<!sjlk<k!u{<{l<!
Noee<x!uixqeK!Hsqk<k!ziZl<!
Ngibk<!OkxzK!Gck<kziZl<!
hioee<x!hgZxg<g!lqviuqpqh<H!
hm<ceqOb!lqgUXkz<!hiv!olb<kz<!
Okoee<x!olipqbii<!Olx<sqf<jk!bikz<!
sQg<gqvlib<!uiklK!oseqg<Gf<!kiOe}/!
.!himz<!355?!hg<gl<!34/!
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“hgvOu!uiklK!Ogihqk<!kh<Ohi!
h{<hig!oh{<Ohig!lKkie<!osb<bqz<!
fgvOu!ouGK~vupq!fmg<gqz<!
ftqvie!gix<XOl!heqOlx<!hm<miz<!
lqgvOu!gib<gt<!geqgqpr<G!ke<je!
lqguVf<kq!lQxqOb!kbqi<kie<!ogi{<miz<!
LgvOu!LKogZl<jh!LXg<gq!ofif<K!
Lpr<giZl<!gj{g<giZl<!gMh<H!d{<miOl”/!
.!himz<!396?!hg<gl<!9:!
!
1. Consumption of bitter, astringent and pungent food items excessively. 
2. Eating food cooked the previous day 
3. Drinking polluted water 
4. Changing Sleep rhythm 
5. Excessive starvation 
6. Lifting heavy objects 
7. Excessive Lust 
8. Sexual indulgence 
9. Walking long distance 
10. Living in chill environment 
11. Excessive consumption of tubers, fruits, curd etc. 
 
2. In Agasthiyar Gunavaagadam 
 
Äokiz<jz!osb<b!-e<El<!ouG!uikOfib<gt<!
okiz<Zzgqz<!lif<kVg<Gg<!gi{<hK{<M!
wz<jzbqz<jz!uikOfib<!Ofi<jlke<je!
-bz<hig!nxqf<kqmOu!uqhvr<!OgOt}!
Äuquvlmi!nskqse<eq!&jt!OfiU!
uqiquie!&jtbK!lqVKuigq!
nueqkeqz<!kqmligh<!OhiukiZl<!
nh<hOe!&k<kqvg<!G{<cg<gib<!uqbikqbiZl<!
kuLequi<!kQi<gig<jg!OlgOvigl<!
ke<jlBt<t!Lk<k{<Mg<!ogic!uqbikq!
nulqzih<!hiqs!fvl<hPk<kr<g{<mib<!
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n[Glmi!uikOfib<!NGl<hiOv}!
Än[Glmi!lilqsk<kqe<!uqbikqbiZl<!
nh<hOe!$kk<kqe<!ohVg<giZl<!
G{lqz<zi!-vsl<!ur<gl<!kqe<eziZl<!
GcogMk<k!uiklK!d{<milh<hi}!
.!ngk<kqbi<!G{uigml<!
 
1. Tiredness 
2. Brain diseases 
3. Renal disorders 
4. Convulsions 
5. Sexually transmitted diseases 
6. Diseases of the vertebral column and Spinal cord 
7. Menorrhagia 
8. Intake of improperly prepared medicines of mercury and lead will cause Vaatha 
disease. 
 
Kanmavinai is also indicated in the aetiology of Vaatha including Kumbavatham. 
The aetiological factors are as follows: 
!
“F~oze<x!uikl<!uf<kujg!kiOeK!
K{<jlbib<g<!ge<lk<kqe<!ujgjbg<!OgT!
gizqOz!Okie<xqbK!gMh<h!OkK!
jggizqz<!Lmg<gqbK!uQg<gOlK!
OgizqOz!hMgqe<x!uqVm<s!lie!
Gpf<jk!lvf<ke<je!oum<mz<Olz<!Okiz<sQuz<!
fizqOz!sQuosf<K!giz<!Lxqk<kz<!
fz<z!ogi{<H!kjp!Lxqk<kz<!fzqk<kz<!kiOe”!
.!himz<!67?!ngk<kqbi<!ge<l!gi{<ml<!411?!hg<gl<!34!
!
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“we<eOu!uikf<ki!oe{<hkiGl<!
-gk<kqOz!leqki<gTg<!ogb<BliX!
hqe<eOu!ohie<ekjeOb!OsivR<osb<K!
ohiqObii<gt<!hqvil{jvk<!K~meqk<Kl<!
ue<e!Okus<!osik<kqz<!OsivR<osb<K!
likihqki!GVju!lxf<k!Ohi<g<Gl<!
ge<eOu!fqf<jk!osb<kiz<!
gibk<kqx<!gzf<kqMOl!uikf<kiOe”!
.!himz<!354?!b,gq!juk<kqb!sqf<kil{q!911?!hg<gl<!87!
!
“Neie!uve<xjeOb!lkqbilif<ki<!
ngkq!hvOksqbi<gm<!ge<e!lQbii<!
Ogieie!GVolipqjb!lxf<k!Ohi<gt<!
ogijz!gtU!ohib<gilr<!Gxqk<k!Ohi<g<G!
Deie!smf<ke<eqz<!uikl<!uf<K!
dx<huqg<Gl<!Oukk<kqe<!d{<jlkiOe”!
.!himz<!364?!b,gq!juk<kqb!sqf<kil{q!911?!hg<gl<!89!
 
1. Cutting trees, peeling of tree bark, cutting tender leaves 
2. Breaking legs of animals 
3. Abusing the elderly people and priests 
4. Exploitation of charitable properties 
5. Ingratitude to Mother, Father and Gurus 
6. Disrespectful attitude towards God 
7. Refusing food for destitute and refugees 
8. Involvement in murder, theft, uttering lies and lustful activities. 
 
PATHOPHYSIOLOGY 
 
Changes in lifestyle, occupation, food and habits lead to the development of 
this disease by causing derangement of micro elements in the body 
(Panchaboothangal). Improper food habits alter the elemental composition directly 
while the other activities cause derangement of these elements indirectly. When 
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elemental composition is altered Uyir Thaathukkal or the three humours which are 
made up of these elements naturally get deranged. This simultaneously leads to 
derangement of seven Udal Thaathukal, which produces symptoms of Kumbavatham. 
Another theory explains that the aetiological factors for Kumbavatham are diet that 
produces excessive Vaayu and other agents which cause vitiation of Vaayu, leading to 
derangement of Pitham and Kabam. 
Here –  
Vali + Aahaayam - Vaatham 
Earth + Water - Kabam 
Fire - Pitham 
 
So Vaatham, Pitham and Kabam are deranged and the Udal Thaathukkal get 
deranged. These changes give rise to clinical features of Kumbavatham. 
 
UYIR THAATHUKKAL 
 
Vaatham – Commonly affected Vaatham are Viyaanan, Samaanan, Naagan, 
Korrman, and Kirukaran. 
 
• Derangement of Viyaanan (Vaayu + Earth) leads to pain in the Shoulder and 
arms, pain along the upper limbs, pain below the umbilicus. 
• Involvement of Samaanan (Vaayu + Aahayam) leads to imbalance of 
functions of other Vaayus. 
• Involvement of Naagan leads to pain in the eyes. 
• Involvement of Koorman leads to burning and tingling sensation in eyes. 
• Involvement of Kirukaran leads to burning sensation in the tongue. 
 
Pitham – Commonly affected Pitham is Saathaga Pitham. 
 
• Involvement of Saathaga Pitham – produces the features like difficulty in 
performing regular duties because of the pain in the Shoulder and upper 
Limbs. 
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Kabam – Avalambagam, Tharpagam and Santhigam are affected. 
 
• Involvement of Avalambagam leads to imbalance of functions of other 
Vaayus. 
• Derangement of Tharpagam produces burning sensation in eyes. 
• Derangement of Santhigam produces pain and stiffness in joints 
 
UDAL THAATHUKKAL 
 
Panchaboothas forming the basic constituents of these Thaathukkal get 
deranged. Commonly affected Udal Thaathukkal are Saaram, Oon, Kozhuppu and 
Enbu.  Nerves and skin are also affected. 
 
GNANENTHIRIYAM 
 
Panchaboothas forming the basic constituents of these Gnanenthiriyams are 
deranged. Commonly affected Gnanenthiriyams are Mei, Kan. 
 
KANMENTHIRIYAM 
 
Panchaboothas forming the basic constituents of these Kanmenthiriyams are 
deranged. Commonly affected Kanmenthiriyams (Organs of action) are Kai. 
 
CLINICAL FEATURES 
 
The signs and symptoms of Kumbavatham are described in the following 
verses. 
 
In Yugi Vaithya Chinthaamani and Yugi Muni Vaithiya Kaaviam 
!
“fuqzOu!Oki{<lQKr<!gvk<kqe<!lQKl<!
fzqf<kolk<k!uigqOb!fsU{<miGl<!
guqzOu!ge<eOliM!fbef<!kiEr<!
gMk<KOl!uqXuqXh<H!oliqUr<!gi[l<!
!
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KuqzOu!Kch<hiGR<!sqvS!ke<eqx<!
Spx<xqOb!fihqg<gQp<!uzqB!L{<mil<!
nuqzOu!nc!fig<gqz<!npe<X!gi[l<!
lzVOl!uVGl<h!uikf<!kiOe”!
.!himz<!375?!b,gq!juk<kqb!sqf<kil{q!hg<gl<!93!
!
“db<bOujgjbh<!hx<xq!BkxqOb!uzqk<Kg<ogiz<Zl<!
olb<bOukqlqVL{<Omi!OleqBl<!uijkgi[f<!!
Kb<bkif<Okitqz<olk<kk<!K{<ck<Kk<K{<ck<Kg<gi[!
jlbuqpqliOkjgbqS!uikole<xqbl<hziOl”!
.!himz<!85?!b,gq!Leq!juk<kqb!giuqbl<?!hg<gl<!32!
 
“Okitkqz<!uQg<gl<!g{<M!!
Kmi<f<kqMl<!hqmiq!g{<[l<!
fitK!&e<xqe<!OlOz!
fz<zOkii<!gMh<Hl<!gim<Ml<!
NtK!sgqk<kqmiK!hiiqz<!
nMk<kqMl<!Okitqz<!uikl<!
StqK!sqvk<Kt<!fQi<!kiEl<!
$p<f<kqcz<!n[Gl<!kiOe”!
.!uikOfib<!lVk<Kul<?!hg<gl<!:4!
!
1. Pain in the Shoulder and arm 
2. Muscle weakness in Shoulder and Arm 
3. Burning sensation and tingling sensation in the eyes and cheeks. 
4. Giddiness and twitching over the scalp 
5. Pain below the Umbilicus 
6. Burning sensation in the Tongue  
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DIAGNOSIS 
 
Diagnosis of Kumbavatham in Siddha is based on 
Ennvagai Thervu (eight types of examination) 
and also on other factors like 
 
• Uyir Thaathukkal 
• Udal Thaathukkal 
• Gnanenthiriyam 
• Kanmenthiriyam 
 
Ennvagai Thervu (Eight types of Examination) 
 
“fich<!hiqsl<!fi!fqxl<!olipq!uqpq!
lzl<!&k<kqvlqju!lVk<KuviBkl<”!
“olb<g<Gxq!fqxf<okieq!uqpq!fiuqVlzl<!jgg<Gxq”!
! ! ! ! .!Okjvbi<!)Ofib<!fimz<!higl<!2?!hg<gl<!364*/!
 
The Eight types of Examination 
1. Naadi (Pulse reading) 
2. Sparism (Tactile sensation 
3. Naa (Tongue) 
4. Niram (Color) 
5. Mozhi (Speech or Voice) 
6. Vizhi (Eyes) 
7. Malam (Stools) 
8. Moothiram (Urine) 
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GENERAL DEFINITION OF EACH TYPE FEATURES IN KUMBAVATHAM 
1. Naadi: 
Naadi means a vital force responsible for birth  
                   – Agathiyar 
 
This vital force is divided into three humours – Vaatham, 
Pitham and Kabam. It can be assessed in 10 sites. The 
commonest site is radial artery. 
In Kumbavatham the Naadi felt are, 
Vaatha Pitham 
Pitha Vaatham 
 
“osiz<zOu!uiklK!lQxqx<!xieiz<!
olz<zOu!jggiz<g!tskq!B{<mil<”!!
!
“ohiVtie!uikk<kqz<!hqk<kR<!Osi<f<K!
jggiz<!kxqh<H!fig<gsg<G!le<el<<”/!
.!Ofib<fimz<!hg<gl<!2,!285,!293 
2. Sparism: 
By Sparism the temperature of the body, smoothness or 
roughness, dryness, hard patches, abnormal growth, sweating, 
swelling, tenderness and nourishment can be felt.  
In Kumbavatham Patients 
General body temperature – slight warmth  
Tenderness present in neck and Shoulders Girdle, upper 
extremities 
3. Naa 
Colour, Coating, Dryness, Movement, Deviation, Sensory 
changes, Ulcer, Conditions of the Tooth and Gums are noted. 
In Kumbavatham Patients 
The tongue shows sensory changes like burning. 
4. Niram 
Colour of the Skin, Mucous Membranes, Hair and Nail are 
examined. 
In Kumbavatham 
General colour – mixed colour (Thonthaniram due to mixed 
Thodams) 
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5. Mozhi 
Disturbances in voice, hoarseness of voice are assessed. 
In Kumbavatham 
No change or disturbance of voice are found 
6. Vizhi 
Testing for – Acuity of vision, Colour – redness, pallor, 
whiteness any burning sensation, excessive lacrimation 
In Kumbavatham 
Burning sensation of eyes is present. In aged patients acuity of 
vision is diminished. 
7. Malam 
The waste and excretory products of body are called as Malam. 
The faeces should be semi-solid without hardness and 
looseness. 
Nature, Quantity, Colour, Odour, Froth, Presence of blood and 
mucus are noted. 
In Kumbavatham 
Some patients have constipation 
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8. Moothiram 
 
The Urine is examined by two methods. 
• Neerkuri 
• Neikkuri 
 
Neerkuri 
 
Urine is collected after taking a well balanced diet (appetite corrected, seasonally 
correlated), which do not alter the three thodams. It should be examined within 3-3/4 
Nazhigai. (90 minutes) 
 
ÄÄuf<k!fQi<g<giqwjm!l{l<!Fjv!wR<soze<!
jxf<kqbZtuju!bjxGK!LjxOb/}}!
.!Okvi<!fQi<g<Gxq!ofb<g<Gxq!F~z<!)sqk<k!lVk<Kuir<gs<!SVg<gl<?!hg<gl<!445*!
 
In Neerkuri the Niram (Colour), Manam (Odour), Nurai (froth), Eadai (specific gravity) and 
Enjal (Quantity) are noted. Apart from these, the frequency of urination, presence of abnormal 
constituents such as sugar, Protein etc., and sediments are also noted. 
 
Neikkuri: 
 
The collected urine is kept in a glass bowl and is placed under direct Sunlight. A drop 
of Gingelly oil is added and nature of Neikkuri is noted. If the drop of oil lengthens like a 
snake it indicates Vaatham, if it spreads like a ring it indicates Pittham, if it appears like a 
pearl it indicates Kabham. 
 
ÄÄnvoue!fQ{<c!e0Ok!uikl<}}!.!Ofib<fimz<!higl<!2?!hg<gl<!38:!
ÄÄNpq!Ohix<hvuqe<!n0Ok!hqk<kl<}}!.!Ofib<himz<!higl<!2?!hg<gl<!38:!
ÄÄLk<okik<K!fqx<gqe<!olipquoke<!ghOl}}!.!Ofib<fimz<!higl<!2?!hg<gl<!391!
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When the drop of oil shows two shapes enclosed within one another it indicates Thondha 
Neer. 
 
Noi Kanippu Vivaadham (Differential Diagnosis) 
 
Some other types of Vaatha disease mimicking Kumbavatham are mentioned. Careful 
and clear history taking and examination will reveal the diagnosis. 
 
They are 
1. Pei Vaatham 
2. Sirakkamba Vaatham 
3. Paanikkamba Vaatham 
4. Atshebaga Vaatham 
 
1. Pei Vaatham (Ohb<!uikl<*!
!
ÄÄohx<xqbil<!ohVjlbir<!giZr<!jgBl<!
ohVubqX!ofMR<OsiM!uqvZ!&g<G!
Wx<xqbi!olxqgPk<K!olr<Gl<!hx<xq!
Wg<glib<!ofif<KUml<!ohr<Gl<!uQr<gq!
dx<xqbi!&{Ou!fqlqi<k<ok!Mk<K!
dXkqbib<h<!hqcg<gU!ol{il!ziGl<!
sg<kqbib<!uib<gsf<K!lbg<g!liGl<!
kiqk<kqmoui{<!{iKOhb<!uikf<!kiOe}}/!
!
.!himz<!387?!b,gq!juk<kqb!sqf<kil{q!.!911?!hg<gl<!97!
 
The clinical features are 
 
1. Pain and swelling in neck, abdomen, upper and lower limbs 
2. Weakness of hand muscles, difficulty in holding things in the hand 
3. Vomiting 
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4. Giddiness 
5. Swelling all over the body 
2. Sirakkamba Vaatham )sqvg<gl<h!uikl<*!
!
ÄÄkl<hlib<!dkqi<g{<m!fvl<hqx<!Hg<gqk<!
kjzObiM!siQvolz<zif<!kig<gqh<!Hg<Gl<!
gl<hlir<!gikqv{<M!lqgUr<!Ogti!
jgObiM!gizqv{<Ml<!usg<Og!miGl<!
fql<hlib<!fqjeOukie<!gzr<gqg<!gi[l<!
ofM&s<Sr<!ogim<miuqfqk<!kqjvB!liGl<!
sql<hlib<k<!kjzfMr<gqg<!geh<H!L{<mil<!
sqvg<gl<h!uikole<Ox!osh<h!ziOl}}/!
.!himz<!411?!b,gq!juk<kqb!sqf<kil{q!.!911?!hg<gl<!:5 
 
The Clinical features are 
1. Stiffness of neck 
2. Deafness 
3. Difficulty in using lower and upper limbs 
4. Confused thinking/impaired memory 
5. Difficulty in breathing 
6. Yawning, excessive sleeping 
7. Tremor in the head and neck 
 
3. Paanikkamba Vaatham (hi{qg<gl<h!uikl<) 
 
ÄÄlii<g<glib<!uib<U!lib<!olb<fq!jxf<K!
ubqXkeqx<!hsqbqzi!K~[!lx<X!
fii<g<glib<!Rizk<K!fmg<jg!bx<X!
fMg<glir<!jgbqv{<Mf<!kqlqV!L{<mil<!
Di<g<gli!Bxg<glqz<zi!K{i<s<sq!bx<X!
dkxqOb!siQvolr<G!Lzi<f<K!gi[l<!
hii<g<glib<!uib<uqm<M!nzk<k!ziGl<!
hi{qg<gl<h!uikk<kqe<!hir<GkiOe}}/!
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.!himz<!377?!b,gq!juk<kqb!sqf<kil{q!.!911?!hg<gl<!94!
 
The Clinical features are 
1. Gaseous accumulation and anorexia 
2. Tingling sensation and numbness of upper limbs 
3. Tremor of upper limbs 
4. Sleeplessness 
5. Dryness all over the body 
 
4. Atshebaga Vaatham )nm<Oshg!uikl<*!
!
ÄÄuikOl!Ogihqk<Ks<!siQvf<!ke<eqz<!
ubqXuqzih<!hg<gr<gt<!uic!Obic!
fikOl!Bm<HGf<K!-Vhk<!kR<S!
fzlxqb!=vjzk<kie<!hx<xq!ofif<K!
gikOl!jggiZ!Olib<k<K!OhiGr<!
geg<gOu!Ofiuigqs<!SVt!ofif<K!
NkOl!nr<golzi!ljsk!ziGl<!
nO]uglil<!uikk<kq!ei{<jl!kiOe}}!
.!himz<!27?!b,gq!juk<kqb!sqf<kil{q?!hg<gl<!672!
 
1. Gaseous accumulation in abdomen and flanks 
2. Pain in liver 
3. Pain and weakness in upper and lower Limbs 
4. Generalised twitching 
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THE ANATOMY 
 
The Vertebral Column :- 
 
The Vertebral column which lodges and protects the spinal cord, its meninges and the 
continuation of the central nervous system lies in the dorsum of the body. It forms a pillar 
which contains 33 segments and lengths about 70cm in an average male and 60cm in a 
female. It supports the body weight and transmits it to the ground through the lower limbs. 
The segments can be divided into cervical, thoracic, lumbar, sarcal and coccygeal segments. 
The cervical segment has seven vertebral bones, thoracic tweleve, lumbar five, sarcal five and 
coccygeal four. All are separate bones except the sacrum and coccyx. 
 
The Curvatures of the Spine:- 
 
There are four curvatures in the vertebral column. They are two primary and two 
secondary curvatures. 
 
The primary curvatures are the thoracic and the sacral. They are convex posteriorly. 
The secondary curvatures are the cervical and lumbar. They are anteriorly convex. The 
cervical curvature becomes prominent when the child is able to hold its head up and fit 
upright. The lumbar curvature appears by 12-18 months after the child starts walking. A slight 
lateral curvature is seen in the upper thoracic region. It is curved to the right in right handed 
persons and vice versa. 
 
The General features of the Vertebrae:- 
 
The Vertebrae can be divided into vertebral body and a dorsal vertebral arch. The 
vertebral arch has 2 pedicles, 7 process and 2 laminae. Pedicles are thick bars projecting 
backward from the body. The laminae are vertical plate like structures, fuses together to form 
spinous process. The spinous process projects downwards and are the lever for the muscles. 
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The articular processes are four in number, bearing the articular facets and articulate with the 
adjacent vertebrae. Transverse processes project laterally from the junction of pedicle and 
laminae. In thoracic region they articulate with ribs. 
 
The Cervical Vertebrae 
 
The Cervical segment of Vertebral column contains 7 Vertebrae. The Cervical spine is 
divided into anterior and posterior columns. The component parts of anterior columns are 
 
• Anterior longitudinal ligament (ALL) 
• Annulus fibrosus (ANN) 
• Unco vertebral Joint 
                             
Posterior Column consists of 
• Nerve root (NR) 
• Facet 
• Superior ligament 
• Posterior Longitudinal Ligament 
 
There are 8 pairs of cervical nerves. Each nerve root contains sensory, motor, 
sympathetic fibers that innervate the upper extremities. The first, second and the seventh 
cervical vertebrae are a typical and the third to sixth are typical. They are smaller and delicate 
than the thoracic and lumbar vertebrae. All the cervical vertebrae have a foramen in the 
transverse process known as foramen transversarium. This is identical to the cervical 
vertebrae.                                                          
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Typical Cervical Vertebrae:-   
 
1. Body :- 
It is small and oval. Its superior surface is concave transversely with upward projecting lips 
on each side and its inferior surface is saddle shaped, convex from side to side and concave 
from before backwards. 
 
2. Vertebral Foramen :- 
 Its larger than the body and triangular. 
 
3. Vertebral Arch :- 
 
i. Pedicles 
 These are short and directed outwards and backwards from the middle of postero 
lateral parts of the body and they form the postero medial wall of the foramen transversarium. 
 
ii. Laminae 
These are long and narrow, being thinner above than below. 
 
iii. Articular Facets 
The superior and inferior articular processes form the articular pillars which project 
laterally at the junction of the pedicle and the laminae. The superior articular facets are flat 
and directed backwards and upwards. The inferior articular facets are also flat but directed 
forwards and downwards. 
iv. Transverse Processes :- 
Each Transverse process is short and pierced by foramen transversarium. Each process 
has an anterior and posterior root which ends in tubercles joined by the costotransverse bar. 
The anterior tubercle of the sixth cervical vertebra is large and is called carotid tubercle. 
 
v. The Spine :- 
It is short and bifid. 
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Foramen Transversarium 
It transmits the vertebral artery, vertebral veins and sympathetic plexus. 
 
The Atypical Cervical Vertebrae :- 
 
1. Atlas :- 
It is the first cervical vertebrae which lodges the skull. It has no body and spine. It has 
anterior and posterior arch, right and left lateral masses and transverse processes. The anterior 
arch bears an anterior tubercle in the anterior aspect. Its posterior aspect bears an oval facet 
which articulates with dens. The posterior surface of the posterior arch has a median posterior 
tubercle. The two lateral masses bear an elongated superior articular facet for atlanto-occipital 
joint and an inferior articular facet for atlanto axial joint. 
The transverse process of atlas is long and thick. It is pierced by the foramen 
transversarium. 
 
2. The Axis :- 
The Axis has a peg like projection in its upper part of the body known as the dens (or) 
odontoid process. It has a circular facet anteriorly articulating with atlas. There are two 
articular facets on either side of the dens on the upper surface of the body. The laminae are 
thick. The spine is large and bifid. The traverse process is small and possess a tubercle in its 
tip. 
                                                                                                                                                                                                                
3. The seventh cervical vertebrae :- 
It is also known as “Vertebral Prominent”. The transverse process does not posses 
anterior tubercle. The foramen transversarium is small (or) absent. It transmits accessory 
vertebral vein only. The spine is long. 
 
Palpable parts of cervical vertebrae :- 
1. The spine of C2 is in the nape 5 cm below the external occipital protuberance. 
2. The spine of C7where the collar bone crosses the posterior medium line of the neck. 
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3. The transverse process of C1 through the anterior border of sternocleidomastoid, 
immediately below the tip of the mastoid process. 
 
Inter-Vertebral Discs 
 
They are fibro cartilaginous discs interposed between the adjacent surfaces of the 
vertebral bodies. They are thicker in lumbar region than in thoracic. Their peripheral parts are 
supplied by the adjacent blood vessels but the central parts are  avascular.  
 
They receive their nutrients by diffusion from spongy bone of adjacent vertebrae. The 
central portion of disc is known as Nucleus Pulposus and the peripheral zone is known as 
Annulus Fibrosus. The central portion is made up of gelatinous mucoid material and it is 
composed of around 80 – 90% of water. On aging it is converted into fibro cartilagenous 
material and its water binding capacity is reduced. Annulus Fibrosus (outer ligamentous ring) 
which hydraulically seals the nucleus and this annulus fibrosus contains collagen bundle in 
periphery and fibro cartilaginous tissue in the inner part. 
 
The annulus has overlapping radial bands, not unlike the piles of a radial artery. The 
thickness of the disc varies daily. In the morning it is thick due to absorption of fluids in lying 
posture and its is thin at night. 
 
Intervertebral Discs – Physiology 
 
1. As a spacer : 
Proper spacing of intervertebral disc allows the intervertebral foramen to maintain its 
height, which allows the segmental nerve roots to exit spinal level without compression. 
 
2. As a shock absorber : 
 
3. As a motion unit : 
The elasticity of the disc allows motion coupling so that the spinal segment can flex, 
rotate and bend to the side all at the same time during a particular activity. 
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4. As a hydraulic cylinder 
The annulus interacts with the nucleus. As the nucleus is pressurized the annular fibres 
serve a containment function to prevent the nucleus from bulging or herniating. The 
gelatinous nuclear material directs the forces of axial loading outward and the hoops of 
annular fibres help to distribute that force without injury. 
 
Joints of the Vertebral Column 
 
The vertebrae from the 2nd cervical to 1st sacral are articulated to one another by a 
series of cartilaginous joints between vertebral bodies and a series of synovial joints between 
the vertebral arches. The vertebral bodies are united by anterior posterior longitudinal 
ligaments and by intervertebral disc of fibro cartilage. 
 
1. Atlanto Occipital Joint 
It is a synovial condyloid variety 
 
Articular ends :- 
Superiorly  - Occipital condyles 
Inferiorly  - Superior articular facet of the atlas 
Adjacent structures - Ligaments, capsule, anterior and posterior occipital membranes 
Blood supply  - Vertebral artery 
Nerve supply  - First cervical nerve 
 
 
Ligaments :- 
1. Capsular ligament 
2. The Anterior Atlanto-occipital membrane 
3. The Posterior Atlanto-occipital membrane 
 
Movements :- 
Flexion, extension and slight lateral flexion are possible. 
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2. Atlanto Axial Joints :- 
 
Consists of  
a. A pair of lateral atlanto-axial joints 
b. Median atlanto axial joint 
 
a. Lateral atlanto-axial joints :- 
Synovial joint - Plane variety  
Articular ends - Inferior facets of atlas and the superior facets of axis 
Ligaments - Ant. longitudinal ligament and ligamentum flavum 
 
 
b. Medial atlanto-axial joint :- 
Synovial joint - Pivot variety 
Articular ends - Between the dens of axis, anterior arch of atlas  
Ligaments - Transverse ligament 
Movement - Rotatory movements around a vertical axis 
 
Ligaments between axis and occipital bone :- 
1. Membrane tectoria 
2. Cruciate ligament 
3. Apical ligament of dens 
4. Linear ligament 
 
The Unco Vertebral (Luschka’s) joints :- 
Luschka’s joints are not true synovial joints; which develop as a result of degenarative 
changes in the edges of the disc in early adult. 
Luschka’s joints are important, because 
i. They are the commonest sites of osteophyte formation. The osteophytes may compress the 
cervical nerves. 
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ii. Vertebral artery lies lateral to the joints intruding on the canal and can cause distortion of 
the artery and leads to Vertebro Basilar insufficiency in atherosclerotic vessels. 
Movements of the Vertebral Column :- 
The greater thickness of the discs in the cervical and lumbar regions as compared with 
the thoracic region is associated with the greater individual range of movements occurring in 
thoracic regions. 
 
Flexion (or) forward bending, extension (or) backward bending, lateral flexion and 
rotation are possible in vertebral column. Numerous muscles are attached directly on the 
vertebrae. 
Movements of the Head and Neck :- 
 
Movements Muscles Nerve Supply 
Sternocleidomastoid Accessory ventral rami of cervical 
spinal nerves C2, C3, C4 
Longus Coli Cervical Ventral rami C2 – C6 
Longus Capitis Cervical Ventral rami C1 – C3 
Flexion 
Rectus Capitis Anterior C1 Ventral ramus 
Splenius Cervicis and Capitis Dorsal cervical nerve 
Erector Spinae Dorsal rami 
Rectus capitis posterior major and 
minor 
Dorsal rami C1 
Obliques capitis superior C1 – Dorsal ramus 
Extension 
Trapezius Accessory 
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Structures passing through : 
a. Foramen Transversarium 
 Vertebral artery, Vertebral vein, Plexus of sympathetic nerve 
 
b. Intervertebral foramen 
 Spinal nerves form dorsal medulla 
 
Blood supply of Vertebral Column :- 
 
 The vertebrae and longitudinal muscles attached to them are supplied by segmental 
arteries. The arteries give multiple small branches to the vertebral bodies. The extensor 
muscles of neck are supplied by the occipital, deep cervial and transverse cervical arteries. 
 
Venous Drinage 
 The Internal vertebral venous plexus lies within the vertebral canal, but outside the 
spinal dura. It receives tributaries from 
 i. The vertebrae through the basilo vertebral veins. 
 ii. The meninges and spinal cord 
 
 The internal vertebral venous plexus is drained by the intervertebral veins, which pass 
out through the intervertebral foramen. Here they are joined by the tributaries from the 
external vertebral and sacral veins. The internal venous plexus communicates with the 
occipital and basilar veins through the forament magnum. 
Sternocleido mastoid Accessory, Ventral rami of Cervial 
spinal nerves C2, C3, C4 
Scalene Cervical Ventral rami C3 – C8 
Longus Coli Cervical Ventral rami C3 – C8 
Levator Scapulae Cervical Ventral rami C3 C4, C5 
Rectus Capitis C1 – Ventral ramus 
Splenius Cervical dorsal ramus 
Lateral 
flexion and 
rotation 
Longismus obliques capitis 
superior and inferior 
C1 Dorsal ramus 
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CERVICAL SPONDYLOSIS 
     
Nomenclature 
      Cervical           -          Neck region 
      Spondylosis - Vertebral ankylosis 
 
Synonyms and related keywords 
 
Cervical Degenerative Joint Disease, Cervical Degenerative Disk Disease, Cervical 
Osteoarthritis, Cervical Spondylotic Myelopathy, Disk Degeneration, Degenerative Cervical 
Disease, Osteophytic Bars, Cervical Radiculopathy. 
 
Definition :- 
 
 Cervical spondylosis is a disorder characterised by increasing degeneration of the 
intervertebral disc, with subsequent changes in the bones and soft tissues. Spondylosis is 
usually asymptomatic. Symptoms are usually manifested by encroachment on local neural 
elements such as cervical nerve roots, spinal cord, vertebral artery (or) sympathetic nerves. 
The symptoms and signs appear to be related to the cause and time course of compression as 
well as the structures being compressed. 
 
Epidemiology 
 
Age  : Cervical spondylosis is present in 5 – 10% over the age of 20 to 30 
years,  
   20 – 25% by the age of 50 years and 70 – 85% by the age of 65 years. 
Sex  : Men are affected more than women. 
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Location 
C5-C6 levels are commonly involved due to maximal movements occurring at this 
cervical spine. 
However C6-C7 and C4-C5 can also be affected at times. 
 
AETIOLOGY 
I. Degenerative Causes 
They are primary and secondary 
Primary - Senility, genetic factors, metabolic factors and manual labour 
Secondary  - Osteoarthritis, rheumatoid arthritis, metastatic carcinoma or  
   lymphomas of the spine and TB spine. 
 
II. Injury 
Automobile accidents with “Whiplash” injury, athletic injury 
Sudden jerks on the arms during fall down 
Previous injury with fracture or disc prolapse 
 
III. Occupational causes 
 The physical discomfort, which arises through an occupation is occupational stress. 
The physical strain, intensity of work and duration of working hours all constitutes the 
occupational strain. 
 
IV. Hereditary factors 
Congenital narrowing of the cervical spinal canal (myelopathy is often seen when 
canal’s sagital diameter is 12mm or loss) 
Segmental defects – Hemi vertebra, fused vertebra. 
 
V. Aquired narrowing of cervical spinal canal due to Osteophytes 
Ossified Posterior Longitudinal Ligament (OPLL) 
Facet joint hypertrophy (results foraminal stenosis and compression of foot of radicular 
artery) 
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Hypertrophied Ligamentum Flavum (Compress the cord during extension). 
Outgrowths of bone that sometimes occur with aging. 
 
Inter vertebral disc protrusions are commonest in the Cervial region which is due to 
degeneration of the intervertebral disc and if it involves several discs with Osteoarthrosis 
liable to interfere with blood supply of the cord and thus leads to further damage. 
 
Pathology 
  
In Cervical spondylosis, involvement of following structures has to be considered. 
 
• Intervertebral disc 
• Unconvertebral joints 
• Apophyseal joints 
• The foramina (intervertebral) and 
• The transverse foramina 
 
Intervertebral disc 
 
All the three parts of disc cartilage plate, nucleus and annulus are involved. 
 
Cartilage plate 
 
First the cartilage plate thins out and cracks. Fissuring and erosion is common. The 
whole plate is replaced by fibrous tissue. 
 
Nucleus 
 
Nucleus becomes fibrous with degeneration. The process of dehydration occurs and 
concludes with reduction in water binding mucoprotein. 
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Annulus 
 
Annulus undergoes some changes as in nucleus. Focal necrosis and calcification is 
common. They form hard ridge within the cervical canal. Osteophytes are formed as a result 
of instability producing stress on the periosteum 
Uncovertebral joints 
 
The unconvertebral joints are most affected as C5-C6 and C6-C7 levels. Progressive 
decrease in disc height the uncinate process approximates against the vertebral body 
undergoes erosion and formation of osteophytes. 
 
Apophyseal Joints 
 
They may remain unaffected for long time. When they are subjected to heavy weight 
pathological changes like erosion, degeneration, lipping and osteophyte formation occurs. 
 
The foramina (intervertebral and transverse) 
 
Foramina are narrowed by fibrosis and posterior longitudinal ligament thickening 
which is not obviously seen on radiography. 
 
Vertebral Artery 
 
Spondylotic changes in the foramina transversarium are not uncommon.  They can 
cause buckling or tortuosity of the vertebral arteries which is commonly found in older age 
group. The artery may also be affected by uncovertebral and apophyseal osteophytes.  
Vertebral artery compression is most common at C4/5 and C5/6 levels. 
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PATHOGENESIS 
 
1.Cervical spondylosis is very common and histological evidence of degenerative changes is 
present  virtually, even present over the age of 70. 
 
2.The disc degeneration, the primary event which is a progressive decrease in the degree of 
hydration.  Glycoproteins diminish in size and number and their ability to retain water 
diminishes.  This results in loss of disc height, disc fibrosis and annular weakening.  Adjacent 
vertebral bodies approximate each other and uneven abnormal movement in the affected areas 
probably results in oseteophyte formation.  These occur at all the joints, namely the disc, 
zygoapophyseal joints and the neurocentral joints of luschka.  Though ostephyte formation 
may be the body’s attempt to stabilize the joints their growth. 
 
3.Ostephytes may form posteriorly with osteoarthritis of the apophyseal joints and also 
anteriorly in relation to degenerative changes and narrowing of the intervertebral disc with 
sclerosis of the bony end plates.  The osteophytes may cause symptoms by encroaching on the 
spinal nerve foramina or in narrowing of the spinal canal and cord compression or in the 
cervical regions on the vertebral artery foramen.  In the cervical region intermittent pain and 
discomfort may be followed eventually by stiffness and limitation of movements. 
 
4.The predisposing factors which may accelerate of these changes viz. 
Occupation requiring repetitive motion and chronic flexion of the Previous injury with 
fracture or disc prolapse. 
Segmentation defects like hemivertebrae or fused vertebrae. 
May be a hereditary predisposition to intervertebral disc disease. 
 
5.Factors responsible for Myelopathy in cervical spondylosis: 
Uncovertebral osteophytes cause anterior compression of cord 
Bony ridges on the posterior vertebral bodies cause central compression on the cord. 
Zygapophyseal osteophytes causing posterior compression 
In curving of the ligamentum flavum causing posterior compression on the cord 
Development of narrow cervical canal 
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Dynamic effect of narrowing of the cervical canal 
Calcification of the posterior longitudinal ligament 
Teethering of the roots to the osteophytes 
Arachnoiditis, postoperative scar 
Interference of blood supply to cord. 
 
CLINICAL FEATURES 
     Symptoms and Signs: 
Symptoms and signs of cervical spondylosis can be acute, subacute or chronic 
occasionally acute exacerbation of chronic symptoms can occur. 
      Symptoms: 
Symptoms can be described as 
1) Neck pain 
2) Radiculopathy 
3) Headache 
4) Myelopathy 
5) VBI [Vertebro Basilar Insufficiency] 
6) Autonomic symptoms 
 
1) Neck pain: 
 Pain is present in nape  and its nature is aching or boring quality, which radiates to the 
shoulder blades top of the shoulder, upper arm and hands or back of the head.  Clinically it is 
very difficult to decide, which disc is responsible to pain.  Patients feel of crunching sounds 
with the movement of the neck or shoulder muscles. 
 
 
2) Radiculopathy: 
 Radiculopathy may be acute in onset. It consists of acute shooting pain usually 
radiating along the dermatomal distribution of the particular nerve root, usually into the 
forearm or fingers. Such each spinal nerve supplies nerves to the bones, joints, muscles and 
blood vessels even when one root is affected the pain is felt in shoulders as well as forearm 
and fingers. Pain is often related to the position of the neck which may itself be painful. There 
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may be muscle spasm. Unlike sciatica it is not made worse as a rule by coughing or sneezing. 
In one type of acute radiculopathy, pain in the neck and muscle spasm may be absent. A 
frozen shoulder is not an uncommon complication of this type of brachial neuritis.  
While in these acute attacks, there may be slight impairment of sensation in the 
affected segment, obvious motor weakness is rare, though when it occurs, it may be quite 
marked with rapid wasting of the muscles. 
 
In chronic radiculopathy, symptoms may come on insiduously or it may be the 
grumbling on of an acute attack.  
 
Neurological deficit specially the sensory disturbance may be more marked. In these 
too, a frozen shoulder is often seen incidentally. 
 
3) Headache: 
 Headache is a common symptom; its pathogenesis is not fully understood.  It is more a 
pain than a headache usually located in occipit on bothsides.  It spreads to the temple or eyes.  
It is described as a tight band round the head. 
 
4) Myelopathy: 
 Myelopathy can be classified in various ways and depends on the involvement of the 
lateral or medial cord or vascular involvement.  The signs may be a mixure of upper motor 
neuron signs in the lower limbs and lower motor neuron signs in the upper limbs. 
 
 Generally myelopathy may be predicated by central disc herniation, but is more 
commonly the result of spondylytic change superimposed on a congenitally narrow canal.  
Motor weakness is rare.  If they occur there may be marked wasting of the muscles. 
 
5) VBI [Vertebro Basilar Insufficiency]:  
 VBI usually requires a combination of arterosclerosis & osteophytes intrusion into the 
foramen transversorium.  The symptoms of this insufficiency are typically a brief attack of 
giddiness without loss of consciousness and generally brought by head movements. 
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6) Autonomic symptoms: 
 Vertigo, flushing, tinnitus & visual blurring are the autonomic symptoms produced by 
cervical disc diseases.  These may be mediated by sympathetic distribution to the 
sinuvertebral nerves from stellate ganglion. 
 
Signs: 
1. Motor 
Atrophy of the hand musculature (Intrinsic muscle atrophy) 
Muscle weakness 
 
2. Sensory 
Loss of vibratory sense or proprioception in the extremites especially in the feet, 
superficial sensory loss. 
 
3. Reflexes 
Hyper reflexia 
Ankle clonus 
4. Babinski’s sign 
5. Lhermitte’s sign positive (Electric shock like sensations down to the center of the 
back following flexion of the neck) 
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Summary of the site of lesion 
 
Cervical spondylosis can produce cord compression (upper motor neuron signs) or 
root compressions (lower motor neuron signs) 
 
Motor Raised elbows (axillary n.) 
Reflex Biceps (musculocutaneous n.) 
Sensory Upper, Lateral arm, near/over deltoid (axillary n.) 
C5 
Pain Upper, Lateral arm, never below elbow 
Motor Elbow supination (radial n.) / pronation (median n.) 
Reflex Brachioradialis (radial n.) 
Sensory Lateral forearm (musculocutaneous n.) 
C6 
Pain Lateral forearm, possibly into thumb 
Motor Elbow extension (radial n.) 
Reflex Triceps (radial n.) 
Sensory Over triceps, mid-forearm and middle finger 
C7 
Pain Deep pain in triceps, front and back of forearm and into middle 
finger 
Motor Thumb index pinch (ant. interosseus n. off median n. at the 
elbow) 
Sensory Medial forearm (antebrachial cutaneous n.) 
C8 
Pain Medial forearm, into the 2 medial fingers 
Motor Finger abduction (ulnar n.) 
Sensory Medial arm (brachial cutaneous n.) 
T1 
Pain Deep pain in axilla and shoulder / some radiation down inside of 
arm. 
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DIAGNOSIS 
 
Mainly based on X-ray 
 
1. X-ray cervical spine 
Anteroposterior (AP) view 
• Lateral view 
• Right Oblique 
• Left Oblique 
• AP Odontoid view 
 
Plain X-rays can demonstrate loss of disc space height, anterior and posterior end-
plate osteophytes, fusion or instability. A lateral view will also show the anteroposterior 
diameter of the spinal canal; and if this is less than 14 mm then cord compression is a real 
possibility. 
 
2. CT Scan 
A CT Scan of your spine uses X-ray technology, but produces a more detailed image 
than X-ray can. 
 
3. Myelogram 
This test involves generating images using X-rays or CT scans after dye is injected 
into the spinal canal. The dye makes areas of your spine more visible. 
 
4. Electromyography (EMG) and Nerve conduction study. 
Needle EMG, nerve conduction studies and evoked potentials may help to 
differentiate spondylotic neurological problems from motor neurone disease, multiple 
sclerosis, peripheral nerve compression and so on. 
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5. MRI (Magnetic Resonance Imaging) 
MRI uses a magnetic field and radio waves and can produce detailed, cross-sectional 
images of your spine. These tests may help your doctor determine the extent of damage to 
your cervical spine. 
 
DIFFERENTIAL DIAGNOSIS 
1. Motor neuron disease 
2. Multiple sclerosis 
3. Syringomyelia 
4. Spinal cord tumors 
5. Tropical spastic paresis from HTLV – 1 infection 
6. Amyotrophic lateral sclerosis 
7. Carcinomatous infiltration or radiotheraphy 
8. Peripheral nerve lesions (distal ulnar or median nerve) 
9. Reffered pain 
 
Cardiac ischaemia 
• Sub-diaphragmatic lesions 
• Gall bladder lesions 
 
COMPLICATIONS 
1. Cord compression-Quadriplegia, spastic gait, affecting the bladder. 
2. Nerve root compression – Neurological injury, Brachialgia 
3. VBI (Vertebro Basilar Insufficiency) 
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TREATMENT OF KUMBAVATHAM 
 
Treatment – Directed towards relief of symptoms like  
Ofib<fic!Ofib<Lkz<!fic!nKk{qg<Gl<!
uib<fic!uib<h<hs<!osbz</! ! ! !
.!kqVg<Gxt<!
!
dx<xie<!ntUl<!hq{qbtUl<!gizLl<!
gx<xie<!gVkqs<!osbz</!! ! ! !
.!kqVg<Gxt< 
 
According to Thiruvalluvar, after diagnosis and finding the etiology, a physician 
prescribes the line of treatment based on patient’s condition, condition of the disease and 
climatic condition. 
 
For Kumbavatham patients, the following line of treatment is given, 
• Purgation 
• Internal Medicine 
• External Medicine 
• Paththiyam 
• Thokkanam 
• Exercise 
• Kanmaneekkam (Expiation)        
 
Purgation:         
“uqOvsek<kiz<!uikl<!kiPl<”!-!Ofib<fimz<!higl<!2,!hg<gl<!359!
 
“nxqf<kqMl<!uikl<!nmr<G!lzk<kqeqz<” – sqk<k!lVk<Kuir<gs<!SVg<gl<!hg<gl<<!97!
!!!!!!!!!!!!!!
Purgation is used to normalize the vitiated Vaatham and eliminate other toxic products of 
digestion, metabolism and catabolism. 
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Purgative medicine: 
 
Agasthiar Kuzhambu – 130mg with hot water at early morning on first day only. 
 
Internal medicine: 
 
Vithurasa Mezhugu – 130mg, twice a day with butter. 
 
External medicine: 
 
Vaatha Ennai – 30ml 
Patthiyam: 
 
Dietary regimen (or) regulation of diet. 
 
The sort of diet to be observed either simple or rigorous depends on various factors 
such as patient’s strength and nature, nature of the disease, quality of medicine, time, climate 
etc.  
 
Patthiyam supports the treatment and produce successful result. 
Substances that should not be consumed are: 
“HtqKuv<!uqR<Sr<gxq!bix<H,vqg<!Gl<uikl<!
ytq!Buv<jgh<!Ohxqz<!hqk<Ks<!sQXl<!.!gqtqolipqOb!
giv<h<hqeqh<H!uqR<sqx<!ghl<uqR<S!R<sm<cvks<!
Osvh<!H{v<!Ofib[giOk” 
hkiv<k<k!G{sqf<kil{q!)Ofib<fimz<!higl<!2, hg<gl<!33*!
 
“-zu{l<!HtqgMou{<!{iZ!Lkzig!
ouiouiV!G{li!obipquiOb!-!fuqzqjxs<sq!
%p<h<hi{<m!ls<sl<!oh{<Osik<kqvr<!ogit<hqvlhk<kqvq!
kQp<h<higq!olk<kuqK!sQ” 
Okve<!ou{<hi!712!)T.V/!sil<hsqul<hqt<!VOL V!hg<gl<!252* 
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Salt, tamarind, mustard, gingelly - any of them should be prohibited as warranted by the 
medicine taken.  Further flesh, fish ash, pumpkin, tobacco, horse gram, and lustful activities 
should be avoided. 
!
hikvs!hk<kqbl<!
!
lx<sLh<H!sQOkim<ce!lf<kikq!uk<ok{<o{b<!
Kx<slk<kq!br<jgh<H!okir<GHtq!–!jbs<sx<Xr<!
%m<milx<!S,kr<!ogiMh<hV{<mi!jvs<sle<hix<!
gm<mil<!xlqVk<kg<!gi{<!
sqgqs<sivk<e!kQhl<,!hg<gl<!42: 
 
Bitter substances, salt, tamarind, gingelly oil, any of them should be prohibited as 
warranted by the medicine taken.  Further fish and cold food items should be avoided. 
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In Siddha System of Medicine “Sirappu Maruthuvam” deals with cure and prevention 
of diseases especially with special treatment techniques such as Yogam, Thokkanam, 
Varmam, in addition to internal medicine and external medicine.  The author has explained 
here the methods of Thokkanam and also some exercise for treating [Kumbavatham] patients 
 
Thokkanam: 
Thokkanam is one of the oldest and simplest forms of siddha treatment.  It improves 
muscle tone, stimulates blood circulation and helps elimination of waste products throughout 
the body.  At its best thokkanam has the potential to restore the individual physically, 
mentally and spiritually. 
 
okig<g{l<! .! okig<G – n{l<!
okig<G! .! Okiz<!
n{l<!! .! nj{f<K!osb<kz<!
 
Thokkanam - A process consisting in striking with fist and then pressing the body or its part 
of a person suffering from some ailment.  On account of this treatment the body grows strong, 
the skin gets luster and the person gets sound sleep. 
okig<g{k<kq!eizqvk<kf<!Okiz<!Deqjugm<G!
lqg<G!sUg<gqbR<s!lQvEl<Ohi!.!olb<g<gkqg!
Hm<cbxg<gl<!H{i<s<sq!bqjugkqg<Gl<!
hm<m!njzs<szXl<!hii<! ! ! ! ! )slQvl<!.!uiB*!
.!ohiVm<h{<H!F~z<!)sqk<ki<!nXju!lVk<Kul<?!hg<gl<!41*!
!
“li<k<keligqb!okig<g{k<kqe<!osbz<!uGh<OhOe!.!ski!
fqf<kLl<!uikl<!hq{qk<k!hq{qh<jhs<!osGh<OhOe!
lz<zgvie!hqmgi<jg!obe<gqx!uitiOz!.!hq{q!
uz<zqjb!olb<bqeqx<!Oskqh<hvif<!kqxjl!uitiOz!
km<mzqXg<gz<!hqck<kz<!LXgz<jg!jkuf<K!.!gvr<!
gm<mzPk<k!zqPk<kz<!lzik<Kkz<!jguf<K!
njsf<kzqu<!ouie<hK!lk<kek<kqf<kqvlieiZl<!.!-kqz<!
-jsk<k!G{r<gjts<!osiz<zh<!OhiG!Oliuc!ObeiZl<”!
.!Okve<!kV!)sqk<ki<!nXju!lVk<Kul<?!hg<gl<!41*!
 47
The nine techniques mentioned in the verse above are the thokkanam procedures 
described in our Siddha system.  In our inpatient ward and outpatient department, the author 
treated the patients of  Kumbavatham with the following thokkanam methods. 
 
1. Azhutthal 
2. Piditthal 
 
Exercise: 
 
Simple movements of the  Shoulder, head, neck and upperlimbs were precribed to 
patients of Kumbavatham. 
 
Expiation: (Kanmaneekkam) 
 
As per Siddha literature, poorvakanmam is one of the reasons for diseases among 
mankind.  It should be expiated. 
 
“fzqbiOz!uf<kge<lf<!kQvoue<xiz<!
fe<lvr<gt<!Okih<H!fjmsijz!juk<kz<!
oktquie!gq{Xoum<mz<!Gtr<gt<!oum<mz<!
okb<ukzr<!Ogibqz<!gm<mk<kQVl<!hiV!
wtqkie!hizgi<g<gi!hv{lQkz<!
we<hoke<x!uikolz<zi!lqjmk<K!OhiGl<!
hpqbieOfib<!uf<kiuqh<hcOb!osb<K!
hkquig!juk<kqbk<jkh<!hqxG!osb<Ob”!
-!himz<!68?!ngk<kqbi<!ge<l!gi{<ml<!.!411?!hg<gl<!34/!
!
To expiate misdeeds of kanma, planting tress, establishing gardens, laying roads and 
pathways, digging wells, pools, lakes, construction of temples, donating ornaments to poor 
children must be done.  These are advised to patients 
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PROTOCOL 
AN OPEN  TRIAL OF “VITHU RASA MEZHUGU” AND “VAATHA ENNAI” 
  FOR THE TREATMENT OF  “KUMBA VATHAM (CERVICAL SPONDYLOSIS)” 
BY 
Dr. S. SENTHIL KUMARI, Dept.of SIRAPPU MARUTHUVAM, NIS. 
1.BACKGROUND: 
 According to the literature of  ‘Anuboga Vaithiya Navaneetham - Part 5’ and 
‘Theraiyar Vaagadam’, ‘Vithu Rasa Mezhugu’ and ‘Vaatha Ennai’ are the preparations 
given for ‘Kumba Vatham’. Vithu Rasa Mezhugu contains Rasam and Seraankottai 
which are very effective anti – vathaa drugs as described in Pathartha Guna Chinthamani. 
2. AIMS: 
    a) Primary aim: 
 To find out the efficacy of Vithu Rasa Mezhugu and Vaatha Ennai for Kumba 
Vatham . 
    b) Secondary aim:  
 To evaluate any adverse effects of the trial drug (if any). 
3. POPULATION: 
   A) About the disease:- 
  In siddha literature the clinical features of Kumba vatham according to Yugi     
muni is given below, 
  “fuqzOu!Oki{<lQKr<!gvk<kqe<!lQKl<!
! ! ! fzqf<kolk<k!uigqOb!fsU{<miGl<!
! ! guqzOu!ge<eOliM!fbef<!kiEr<!
! ! ! gMk<KOl!uqXuqXh<H!oliqUr<!gi[l<!
! ! KuqzOu!Kch<hiGR<!sqvS!ke<eqx<!
! ! ! Spx<xqOb!fihqg<gQp<!uzqBL{<mil<!
! ! nuqzOu!nc!fig<gqz<!npe<X!gi[l<!
! ! ! lzVOl!uVGl<h!uikf<kiOe”/!
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! we<hkiz<?!-f<Ofibqz<!Okit<hm<jm?!jg?!Lkzqb!-mr<<gtqz<!lqg<g!OfiB{<migq!nju!
fQm<mUl<! Lmg<gUl<! ym<milz<! OfiGl<?! ge<eLl<?! g{<[l<! gMk<K! uqXuqXk<K! wiqU{<miGl<!
dmz<! Kck<K?! kjz! Sx<xq! lqG! SvL{<mib<! fihqbqe<! gQp<! uzqBl<! nc! fig<gqz<!
npx<sqBL{<miGl</!
B) ACCORDING TO MODERN MEDICINE, CLINICAL FEATURES OF 
CERVICAL    SPONDYLOSIS ARE:- 
1. Pain in the neck radiating down to arm. 
2. Pain radiates to shoulder, arms and hands with restriction of movements.  
3. The neck is held rigidly and neck movements may exacerbate pain. 
4. Paresthesia and sensory loss may be found in affected segment. 
5. Headache in the occipital region, on one or both sides and may spread into the temple 
or into one eye.  
6. Burning and tingling sensation in the upper limbs especially extension of the neck. 
7. Giddiness (or) drop attacks precipitated by neck movements. 
8. Muscle weakness. 
4. SAMPLE: 
 Kumba Vaatham Patients reporting at OPD - Ayothidoss Pandithar Hospital in 
National Institute of Siddha, Tambaram Sanatorium, Chennai- 47. 
SAMPLE SIZE: 
 It is proposed to study a sample of 40 patients (20 In patients and 20 
Outpatients) 
STUDY DESIGN: 
 Clinical trial of cases of Kumba vatham (Cervical spondylosis) treated with 
Vithu Rasa Mezhugu and Vathaa Ennai for a period of 20 days. 
a) INCLUSION CRITERIA: 
1. Age:  between 25 years and 60 years. 
2. Sex:  Both Male and Female 
3. Pain in the neck radiating to shoulder and arm. 
4. Occipital headache, giddiness generally by neck movement. 
5. Diabetics with the above symptoms. 
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   b) EXCLUSION CRITERIA: 
1. History of  trauma  
2. Hypertension  
3. Cardiac diseases 
4. Narcotic addicts 
5. Pregnancy 
6. Lactation 
7. Patients with any other serious 
illness 
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      c)  TERMINATION CRITERIA: 
1. Development of any adverse reaction (ADR).  
2. Occurrence of any other serious illness. 
      d) TRIAL DRUG AND DURATION: 
 1. PURGATIVE             : Agasthiyar Kulambu - 130mg at early morning on 
the  
                                         first day only. 
 2. INTERNAL DRUG   : Vithu Rasa Mezhugu, 130 mg twice a day with 
butter   
                                           for 9 days 
 3. EXTERNAL DRUG(Along with internal drug): Vaatha ennai, 30-50 ml 
for  
                                           external application twice a    day for 20 days. 
 4. TRIAL PERIOD        : 20 days for each patients. 
5. STUDY PERIOD:  6 months 
6. RECRUITMENT: As and when patients with inclusion criteria are reporting, they 
will be included in the study with their consent. The recruitment will take a period of 5 
months. Kumba Vatham patients satisfying inclusion and exclusion criteria will be 
eligible for admission to the trial. Informed consent will be obtained from the patients. 
7. TESTS AND ASSESSMENTS: 
RADIOLOGICAL TESTS:    X-ray cervical spine 
ROUTINE INVESTIGATIONS:   
BLOOD - TC, DC, ESR, Hb, Blood sugar, Serum cholesterol, Blood Urea, 
Serum creatinine 
            URINE  -  Albumin, Sugar, Deposit 
            STOOLS  - Ova, cysts, occult blood 
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8. ASSESSSMENT BY SIDDHA ASPECTS:  
En vagai thervugal and Mukkutra assessment. 
SIDDHA ASPECTS (According to Yugi Vaithiya Chinthamani): 
• Pain in the shoulder and arm 
• Muscle weakness in shoulder and arm 
• Burning sensation and tingling sensation in the eyes and cheeks 
• Giddiness 
• Pain below the umbilicus  
• Burning sensation  in the tongue 
 9. METHODOLOGY OF TREATMENT: 
 A day before starting trial treatment, Purgation will be given for balancing the 
mukkutras.  
 For In patients, the trial drugs will be given daily in the IP Department of Sirappu 
Maruthuvam of APH. The clinical assessment will be made daily and laboratory 
investigations will be done on the first day, 10th day and 20th day of the treatment. The 
radiological investigations will be done before and after the treatment. 
For out patients, the trial drugs will be given in the Outpatiet Department of our 
APHospital. The patients will be asked to follow regular check up in the OP Department. 
In each visit, the clinical assessment will be made regularly. The laboratory investigations 
and radiological investigations will be done before and after treatment. 
10.  DATA COLLECTION FORMS: 
Required information will be collected from each patient by using forms I, II. 
 FORM I – SELECTION PROFORMA – At the time of admission of the 
patient to  the study.    
 Form II – CLINICAL ASSESSMENT PROFORMA – during study period. 
11. ANALYSIS: 
 Normal proportion test for determining the significance of treatment 
 Mean of objective parameters – before and after treatment - paired‘t’ test. 
 
 
 51
 
 
 
 
RESULTS AND OBSERVATION 
 
 
Results of the study were observed with respect to the following criteria. 
 
 
1. Sex distribution 
2. Age distribution 
3. Kaalam (Life span) 
4. Paruvakaalam 
5. Diet 
6. Thinai 
7. Socio economic status 
8. Derangement of Mukkutram 
9. Envagai thervugal 
10. Derangement of Udalthaathukkal 
11. Derangement of Kanmenthriam 
12. Duration of illness 
13. Associated history 
14. Clinical features 
15. Precipitating factors 
16. Occupational status 
17. Radiological findings 
18. Degree of Shoulder movements 
19. Preclinical studies 
20. Result of treatment 
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RESULTS AND OBSERVATION 
Table 1 Gender distribution  
Cases Gender 
No. Percentage 
Male 17 42.5 
Female 23 57.5 
Total 40 100.0 
Observation: 
Out of  40 patients recruited for the study, 57.5% were females. 
Table 2 Age distribution  
Cases Age 
(years) No. Percentage 
21-30 1 2.5 
31-40 12 30 
41-50 12 30 
51-60 15 37.5 
Total 40 100.0 
Observation: 
Out of  40 patients, 37.5% were in the age group of  51 – 60. 
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Table :3 Kaalam (Life span) 
Cases Kaalam 
No. Percentage 
Vaathakaalam (up to 33 yrs) 3 7.5 
Piththaakaalam (34-66 yrs) 37 92.5 
Kaba Kaalam (above 67 yrs) 0 0 
Total 40 100.0 
Observation: 
Out of 40 cases, 92.5% of the cases were found to be in Piththakaalam i.e. 
between 34 –66 years. 
4.  Paruvakaalam 
Among 40 patients, 36(90%) cases were admitted to the trial in kaarkaalam and 
the remaining 4 (10%) cases were admitted in koothirkaalam 
No case was admitted in Munpanikaalam, Pinpanikaalam Elavenil Kaalam, 
Muthuvenil Kaalam. 
5. Diet 
Cases Diet 
No. Percentage 
Vegetarian 3 7.5 
Non-Vegetarian 37 92.5 
Total 40 100.0 
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Observation:  
       Out of 40 cases 92.5% of cases were non-vegetarians and  7.5% of cases vegetarians. 
6.  Thinai: 
 Most of the cases (100%) were reported from Neithal thinai. 
 Neithal thinai, which is responsible for vaatha diseases, may be the reason 
for the higher incidence. 
6.  Socio economic status: 
Cases Socia Economic Status 
No. Percentage 
Poor 10 25 
Middle class 25 62.5 
Rich 5 12.5 
Total 40 100.0 
Observation: 
 62.5% of patients belong to middle class income group. 
7.  Disturbances in Vaatham: 
 Out of 40 cases observed viyaanan and samanan were affected in almost all the 
cases while abanan affected in 5 cases, koorman affected in 3 cases 
8.  Disturbances in Piththam: 
 Out of 40 cases, Saathagam was affected in almost all cases. 
9.Disturbances in Kabam: 
 Only Santhigam was affected in all the 40 cases. 
10.  Envagai Thervugal (Siddha Diagnostic Parameters) 
 Examination of Naadi revealed Vathapitham (Thontha Naadi) in all the cases; 
Sparism revealed tenderness in 52.5% of cases; Constipation was found in 5% of cases 
and impaired vision in 8.3% of cases. 
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11. Naadi 
Cases 
Naadi 
No. Percentage 
Vaatham 0 0 
Vaathapitham 40 100 
Piththavaatham 0 0 
Piththakabam 0 0 
      Total 40 100 
                           All the cases were diagnosed  as having Vathapitham  
12.  Neikuri 
Cases Spreading Pattern 
No. Percentage 
Aravenaneendathu 11 18.3 
Aazhipolparaviathu 0 0.0 
Muththupol Ninrathu 29 81.7 
Total 40 100.0 
Out of 40 patients, Neerkuri revealed 81.7% were Kaba neer and 18.3% 
were vaatha neer. 
13. Udal Thathukkal: 
 Enbu was affected in all 40 cases (100%) . 
 Saaram also affected in all 40 cases (100%) 
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14.  Disturbances in Kanmenthiriyam: 
 Kai was affected in all 40 cases (100%) 
15.  Duration of Illness: 
Cases  Duration of Illness 
(month) No. Percentage 
Up to 6 months 22 55 
7 – 12  months 8 20 
13 –18 months 0 0 
19 – 24 months 5 12.5 
25 – 30 months 0 0.0 
Above 30 months 5 12.5 
Total 40 100.0 
55% of patients reported with  6 months duration of illness 
16.  Involvement of Shoulder Joints 
Cases Shoulder Joints 
No. Percentage 
Both Shoulder Joints 8 20 
Right Shoulder joint only 12 37.5 
Left Shoulder Joint only 20 42.5 
Total 40 100.0 
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17.  Clinical Features 
Cases Clinical Feature 
No. Percentage 
Pain in shoulder  40 100.0 
Pain in upper limbs 40 100.0 
Numbness 23 57.5 
Tenderness 21 52.5 
Stiffness 30 75 
Headache 15 37.5 
 Burning sensation of the eyes 10 25 
Burning sensation of the tongue 1 2.5 
Pain below the umbilicus 5 5 
Restriction of  movements 40 100.0 
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18.  Precipitating Factors: 
Cases Factors 
No. Percentage 
Menopause 11 27.5 
Heavy household works 10 25 
Occupational related 20 50 
History of trauma 2 10 
Diabetis Mellitus 7 17.5 
19.  Occupation: 
Cases Occupation 
No. Percentage 
Clerk 13 32.5 
Teacher 3 7.5 
Watchman 2 5 
Tailor 2 5 
Farmer 10 25 
Household works 10 25 
Total 40 100.0 
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20.  Results: 
Cases Results 
No. Percentage 
Clinically Releived 6 15 
Good Improvement 27 67.5 
Moderate Improvement 5 12.5 
No Improvement 2 5 
 
              
            
 
 
 
 
 
 
 
 
 
RESULT OF TREATMENT 
Clinically Releived 
Good Improvement
Moderate Improvement 
No Improvement
67.5%
15%5%12.5% 
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21. Degree of Shoulder Movements: 
 
 
Degree of Shoulder 
Movements   
 
 
 
SI.NO 
 
 
PATIENT NO 
BT AT 
1. 1515 60 120 
2. 1525 50 110 
3. AL 6409 110 170 
4. AI 5794 120 160 
5. AM 3183 60 130 
6. 1127 80 180 
7. 1141 90 180 
8. 1133 70 100 
9. AM 7096 120 160 
10. AM 7162 120 180 
11. 1156 50 120 
12. 1640 90 90 
13. 1152 110 130 
14. 1214 50 70 
15. 1231 30 50 
  
 
0
20
40
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AFTER 
TREATMENT
SI.NO 2 4 6 8 10 12 14
BEFORE TREATMENT
DEGREE OF SHOULDER MOVEMENTS BT
AT
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Paired t test - comparision of Degree of shoulder movement before and 
after treatment 
 
-----------------------------------------------------------------------
------- 
Variable |     Obs        Mean    Std. Err.   Std. Dev.   [95% Conf. 
Interval] 
---------+-------------------------------------------------------------
------ 
    debt |      40      142.75    8.219641    51.98557    126.1242    
159.3758 
    deat |      40      161.25    5.514404    34.87615    150.0961    
172.4039 
---------+-------------------------------------------------------------
------ 
    diff |      40       -18.5    4.662315    29.48707   -27.93042   -
9.069578 
-----------------------------------------------------------------------
------- 
 
                   Ho: mean(debt - deat) = mean(diff) = 0 
Ha: mean(diff) < 0         Ha: mean(diff) ~= 0        Ha: mean(diff) >0 
     t =  -3.9680                t =  -3.9680              t =  -3.9680 
 P < t =   0.0002          P > |t| =   0.0003          P > t =   0.9998 
 
 
 
 
 
 
 
 
22. Genderwise prognosis 
 
RESULT FEMALE MALE TOTAL 
C.R 3 3 6 
G.I 16 11 27 
M.I 3 2 5 
N.I 1 1 2 
TOTAL 23 17 40 
 
 
  C.R = Clinically Releived 
  G.I =   Good Improvement 
  M.I =    Moderate Improvement 
  N.I    =  No Improvement 
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ROUTINE HAEMATOLOGICAL INVESTIGATIONS (OP cases) 
 
 
 
                                                                                                                                                                                                                                                            
  BT = Before Treatment          AT = After Treatment 
 
 
 
 
 
 
 
 
 
 
  TC 
(Cumm) 
DC(Cumm) 
 
Hb 
(mg/dl) 
    Blood 
Sugar(mg%) 
Blood 
Urea(mg
%) 
  Blood 
Cholester
ol 
(mg%) 
ESR(mm)
   BT(%)     AT (%)   BT AT BT BT AT 
P L E M P L E M 
BT AT 
F PP F PP 
BT AT BT AT 
1/2h
r 
1h
r 
AL6409 6900 7200 50 45 5 0 53 42 5 0 12.5 9.2 198 300 120 192 25 20 252 253 13 40 
 7300 7100 52 43 5 0 50 46 4 0 12.1 12.8 85 123 79 110 18 20 187 192 4 8 
 6800 7000 54 42 6 0 51 47 2 0 13.2 12.8 80 107 70 108 22 24 231 235 10 20 
 8900 6800 56 42 2 0 56 39 5 0 12.5 14.1 108 118 20 19 155 191 2 4 
AM3183 7000 7100 50 46 4 0 52 43 5 0 9.7 10.8 85 104 90 107 19 20 244 238 30 63 
 6400 8000 58 40 2 0 53 44 3 0 9.7 10.8 247 216 18 18 158 163 4 10 
AL7832 7000 8000 55 42 3 0 53 45 2 0 9.2 10.5 82  74 22 15 167 147 2 4 
AM5387 7000 7200 54 43 3 0 55 42 3 0 11.8 12.1 89 
 
112 85 114 23 21 234 245 4 8 
AM7096 6900 7800 55 43 2 0 52 45 3 0 11.1 11.8 125  96 112 31 32 245 236 2 4 
AM7162 7000 7400 52 46 4 0 51 46 3 0 10.2 11.4 81  81  24 28 194 155 6 12 
 7200 8100 58 38 4 0 53 45 2 0 12 13 70  78  32 34 198 187 4 8 
 7200 7500 56 40 3 1 53 42 5 0 9.2 10.2 113  109  35 28 222 231 10 22 
AM9152 8600 7800 56 41 3 0 57 39 3 1 14.6 12.5 99  81  44 23 203 219 2 4 
 7900 8200 60 37 3 0 53 45 2 0 9.8 12 85  104  16 19 - 240 22 44 
AM8976 6800 7500 52 45 3 0 53 42 5 0 9.7 11 95  88  27 18 170 165 8 16 
G8071 6200 8000 50 48 2 0 42 48 4 0 13 14 171 - 256  16 31 - 210 4 10 
AN7073 7800 6900 53 42 3 2 52 46 2 0 12.5 12 70  78  17 16 154 166 4 8 
AN6125 8200 8900 54 42 4 0 51 46 3 0 13.1 12.5 112  124  27 29 189 198 2 4 
AO1510 8100 8200 53 44 3 0 52 45 2 1 8.7 10.8 119  110  20 25 268 257 18 36 
AK2619 7800 8200 53 42 5 0 55 43 2 0 10.2 11.2 107  102  24 26 150 153 15 32 
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ROUTINE HAEMATOLOGICAL INVESTIGATIONS (IP cases) 
 
 
 
 
 
 
 
 
 
                BT = Before Treatment          AT = After Treatment 
 
 
 
 
 
 
 
 
 
 
 
 
TC(Cumm) DC(Cumm) Hb(mg/dl) Blood Sugar(mg/dl%) Blood 
Urea 
(mg%) 
Blood 
Cholesterol 
(mg%) 
ESR(mm) 
BT AT BT AT BT AT
F 
 
PP 1/2hr 1hr PP 
 
 
SI 
.NO 
IP. 
NO 
 
BT 
 
AT P L E M        P L E M 
BT AT 
F 
  
 
BT AT BT AT 
  
1/2hr
1. 1060 7800 6100 60 37 3 0 51 47 2 0 11.1 12.1 89 106 88 114 21 30 186 221 42 85 8 
2. 1515 5800 6600 52 45 3 0 53 36 8 3 11.1 13.2 78 106 108 124 17 24 190 176 12 26 8 
3. 1525 8900 5900 62 37 1 0 50 49 1 0 13.5 12.1 167 246 72 - 18 21 173 171 44 88 20 
4. 3015 7400 6100 56 42 1 0 54 44 2 0 11.6 11.1 124 169 116 152 26 27 280 188 4 8 10 
5. 1140 6400 7800 57 38 1 4 54 40 5 1 10.7 12.7 91 116 70 116 26 25 194 189 10 20 15 
6. 1141 7000 6200 56 42 2 0 57 38 4 0 7.7 10.3 221 400 151 288 19 19 314 - 4 8 15 
7. 1127 7400 6500 60 39 1 0 65 32 3 0 10.6 10.6 81 114 69 106 18 19 239 167 8 16 16 
8. 1621 810 6600 57 40 3 0 52 40 2 0 14 10.2 81 99 73 111 30 33 208 218 2 4 2 
9. 1133 7000 6900 57 41 2 0 55 45 4 1 7.7 10.2 117 268 273 - 27 28 209 209 10 20 10 
10. 1614 8200 7300 54 42 4 0 62 35 2 1 13.1 9.7 73 90 93 131 25 34 - 227 5 10 12 
11. 1156 6500 7800 48 48 4 0 53 42 4 1 9.2 8.9 86 98 74 110 18 18 166 - 6 12 22 
12. 1640 6100 8000 52 42 6 0 53 44 3 0 9.2 12 63 110 70 94 21 16 150 137 100 200 70 
13. 1214 9400 7000 58 38 2 0 53 42 5 0 11.1 10 82 115 78 - 30 30 - 196 16 32 22 
14. 1607 7100 7400 62 36 2 0 55 43 2 0 14.5 13.1 86 145 82 87 22 27 222 251 4 8 4 
15. 1198 7400 7300 52 42 2 4 51 40 4 5 9.8 10.4 118 235 79 134 28 20 - - 20 40 12 
16. 1152 6600 7800 56 41 3 0 58 38 4 0 9.7 9.8 103 120 94 208 23 18 240 - 14 28 12 
17. 1652 6500 7000 54 42 4 0 53 42 5 0 10.6 13.1 95 127 80 116 21 20 248 - 6 12 12 
18. 1176 7100 6100 65 31 4 0 55 43 2 0 9.7 9.8 252 331 251 369 27 18 250 - 8 16 4 
19. 1231 9800 7000 50 44 6 0 52 44 6 0 11.5 10.2 118 - 84 157 20 22 - 189 20 40 14 
20. 1791 7200  52 46 2 0 50 41 8 1 14 14 75 104 87 103 20 25 146 160 10 24 4 
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  HAEMATOLOGICAL INVESTIGATIONS (OP cases) 
 
 
 
 
 
 
 
                    BT = Before Treatment      AT = After Treatment     T. = Total 
 
 
 
 
       
 
 
 
 
 
 
 
 
 
 
 
 
SI.NO OP.NO LIVER FUNCTION TESTS RENAL FUNCTION TESTS 
  BT AT BT AT BT AT BT AT BT AT BT AT 
  T.BILIRUBIN SGOT SGPT SAP CREATININE T.PROTEIN 
1. AL6409 0.8 0.7 18 17 17 16 - - 0.6 0.6 7.2 7.6 
2. AI5794 0.6 0.7 15 17 20 19 123 - 0.8 0.9 7.8 7.3 
3. AL039 0.3 0.4 21 22 24 21 142 135 0.6 0.7 6.1 5.9 
4. AI5144 0.4 0.6 25 24 28 20 124 133 0.6 0.7 7.7 6.9 
5. AM3183 1.1 0.8 19 20 17 16 123 - 0.7 0.6 8.1 7.8 
6. AJ3676 0.8 0.7 28 11 24 10 - - 0.6 0.5 7.2 7.6 
7. AL7832 0.6 0.6 13 10 10 9 181 - 0.8 0.5 7 6.8 
8. AM5387 0.4 0.6 20 21 18 17 - - 0.7 0.7 7.5 7.3 
9. AM7096 1 1.1 32 28 28 19 222 167 1 0.8 7.5 7.2 
10. AM7162 1.2 0.8 34 24 30 21 206 205 0.9 0.9 7.3 7.2 
11. AJ3454 1.1 0.9 20 21 20 23 - 134 1 1.1 7.2 7.3 
12. AJ3692 2.8 1.2 21 24 18 20 137 123 1 0.8 7.9 7.2 
13. AM9512 0.9 0.8 24 29 20 26 147 197 1.1 0.6 7.5 6.5 
14. AJ8019 0.8 0.8 17 17 15 15 - 220 0.5 0.7 6.4 7.9 
15. AM8976 0.6 0.7 17 11 13 9 124 143 0.9 0.6 7.3 7.7 
16. AG8071 0.5 0.5 13 17 12 19 137 166 1 0.8 7.7 6.4 
17. AN7073 0.6 0.7 12 23 10 21 - 177 0.6 0.6 7.6 8.9 
18. AN6125 0.6 0.6 13 16 11 10 - - 0.7 0.6 6.3 5.7 
19. AO1510 0.6 0.5 18 12 12 16 229 189 0.9 0.6 7.2 7.1 
20. AK2619 3.6 1.1 23 20 21 23 153 147 0.7 0.8 7.4 6.8 
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  HAEMATOLOGICAL INVESTIGATIONS (IP cases) 
 
 
 
 
 
 
SI.NO IP.NO LIVER FUNCTION TESTS RENAL FUNCTION TESTS 
  BT AT BT AT BT AT BT AT BT AT BT AT 
  T.BILIRUBIN SGOT SGPT SAP CREATININE T.PROTEIN 
1. 1060 0.8 0.7 25 24 23 21 - - 0.9 0.9 7.4 7.4 
2. 1515 0.6 0.6 23 22 18 18 - - 0.6 1.1 7.1 7.1 
3. 1525 1.3 1 21 20 20 20 - - 1.1 0.9 8.9 7.8 
4. 3015 0.7 0.6 46 37 43 35 111 121 0.9 0.9 8 7.6 
5. 1140 0.6 0.6 22 16 18 14 205 - 0.8 0.4 8.8 7.6 
6. 1141 0.6 0.7 32 25 28 21 220 - 0.6 0.5 7.4 7.2 
7. 1127 0.5 3.5 13 18 16 15 224 188 0.6 0.6 7.4 6.9 
8. 1621 0.8 0.6 29 31 27 63 154 185 0.9 0.8 7.7 7.3 
9. 1133 0.8 0.7 38 40 32 38 437 283 0.8 0.7 7.9 7.1 
10. 1614 0.8 0.7 23 25 31 22 158 134 0.8 1 7.4 7.7 
11. 1156 0.7 0.7 34 18 24 16 146 - 0.6 0.8 17 7.7 
12. 1640 0.8 0.7 12 19 11 16 159 157 0.7 0.5 7.4 7.6 
13. 1214 0.8 0.9 32 31 45 25 - 187 0.9 0.8 7.8 7.2 
14. 1607 1 0.5 71 38 66 38 189 200 1 0.6 6.2 6.8 
15. 1198 0.6 0.7 21 22 22 20 - - 0.8 0.7 7.4 7.1 
16. 1152 0.8 0.6 25 24 22 21 198 - 0.8 0.6 7.5 7.9 
17. 1652 0.7 0.7 17 16 15 14 194 - 0.7 0.7 7.8 7.4 
18. 1176 0.7 0.8 18 22 16 20 289 - 0.8 0.7 7.4 8.8 
19. 1231 0.6 0.6 22 21 20 19 141 141 0.6 0.8 7.3 7.8 
20. 1791 0.7 0.8 21 24 20 20 224 193 0.7 0.8 7.3 7.8 
 
 
                     BT = Before Treatment      AT = After Treatment     T. = Total 
 
 
 
 
 
 
                                                                                                                                                                                                                                                            
        
 
 
 
 
 
 
 
 
 
 
 
 
 66
 
   URINE ANALYSIS (OP cases) 
 
 
 
 
          PC = Pus Cells   EC = Epithelial Cells 
 
 
 
 
 
        
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Before treatment 
 
After treatment Before treatment After treatmentSI.NO OP.NO 
 
Albumin 
 
Sugar 
 
Deposits 
 
Albumin 
 
Sugar 
 
Deposits 
 
Ova 
 
Cyst 
Occult 
blood 
 
Ova 
 
Cyst
1. AL6409 Nil + 1-2PC,0-1EC Nil Nil 1-2PC,1-2EC Nil Nil Nil Nil Nil
2. AI5794 Nil Nil 2-3PC,2-3EC Nil Nil 1-2PC,01EC Nil Nil Nil Nil Nil
3. AL039 Nil Nil 0-1PC,2-1EC Nil Nil 1-3PC,0-2EC Nil Nil Nil Nil Nil
4. AI5144 Nil Nil 2-3PC,1-2EC Nil Nil 2-3PC,0-1EC Nil Nil Nil Nil Nil
5. AM3183 Trace Nil 3-5PC,4-5EC Nil Nil 1-2PC,0-1EC Nil Nil Nil Nil Nil
6. AJ3676 Nil Nil 1-2PC,102EC Nil Nil 3-4PC,2-5EC Nil Nil Nil Nil Nil
7. AL7832 Nil Nil 1-2PC,0-1EC Nil Nil 1-2PC,0-1EC Nil Nil Nil Nil Nil
8. AM5387 Nil Nil 2-3PC,2-4EC Nil Nil 1-2PC,0-1EC Nil Nil Nil Nil Nil
9. AM7096 Nil Nil 1-3PC,1-2EC Nil Nil 0-2PC,0-2EC Nil Nil Nil Nil Nil
10. AM7162 Nil Nil 1-3PC,0-1EC Nil Nil 4-6PC,2-4EC Nil Nil Nil Nil Nil
11. AJ3454 Nil Nil 1-2PC,0-1EC Nil Nil 2-3PC,1-2EC Nil Nil Nil Nil Nil
12. AJ3692 Nil Nil 1-2PC,1-2EC Nil Nil 2-3PC,2-4EC Nil Nil Nil Nil Nil
13. AM9512 Nil Nil 1-2PC,2-4EC Nil Nil 2-3PC,1-2EC Nil Nil Nil Nil Nil
14. AJ8019 Nil Nil 1-2PC,1-2EC Nil Nil 0-1PC,2-4EC Nil Nil Nil Nil Nil
15. AM8976 Nil Nil 1-2PC,0-1EC Nil Nil 1-2PC,1-2EC Nil Nil Nil Nil Nil
16. AG8071 Nil + 2-3PC,1-2EC Nil Nil 1-2PC,2-5EC Nil Nil Nil Nil Nil
17.  AN7073 Nil Nil 2-3PC,2-4EC Nil Nil 2-3PC,2-3EC Nil Nil Nil Nil Nil
18. AN6125 Nil Nil 2-4PC,0-1EC Nil Nil 2-3PC,1-2EC Nil Nil Nil Nil Nil
19. AO1510 Nil  Nil  1-2PC,1-2EC Nil Nil 0-1PC,0-1EC Nil  Nil Nil  Nil  Nil 
20. AK2619 Nil Nil 4-6PC,2-4EC Nil  Nil  3-4PC,1-2EC Nil Nil  Nil Nil Nil
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URINE ANALYSIS (IP cases) 
 
Before treatment After treatment Before treatment After treatmentSI.NO IP.NO 
 
Albumin 
 
Sugar 
 
Deposits 
 
Albumin 
 
Sugar 
 
Deposits 
 
Ova 
 
Cyst 
Occult 
blood 
 
Ova 
 
Cyst
1. 1060 Nil Nil 3-4PC,2-4EC Nil Nil 2-4PC,23EC Nil Nil Nil Nil Nil 
2. 1515 Nil Nil 2-4PC,2-4EC Nil Nil 1-2PC,1-2EC Nil Nil Nil Nil Nil 
3. 1525 Nil Nil 2-4PC,2-4EC Nil Nil 3-4PC,2-4EC Nil Nil Nil Nil Nil 
4. 3O15 Nil Nil 1-2PC,0-1EC Nil Nil 2-3PC,2-3EC Nil Nil Nil Nil Nil 
5. 1140 Trace Nil 1-2PC,2-4EC Nil Nil 1-2PC,1-2EC Nil Nil Nil Nil Nil 
6. 1141 Nil Nil 2-3PC,0-1EC Nil Nil 2-3PC,0-1EC Nil Nil Nil Nil Nil 
7. 1127 Nil Nil 1-3PC,1-2EC Nil Nil 2-3PC,1-3EC Nil Nil Nil Nil Nil 
8. 1621 Nil Nil 1-3PC,1-2EC Nil Nil 1-2PC,1-3EC Nil Nil Nil Nil Nil 
9. 1133 Nil + 1-2PC,0-1EC Nil ++ 2-5PC,Plenty  Nil Nil Nil Nil Nil 
10. 1614 Nil Nil 1-2PC,1-3EC Nil Nil 1-3PC,1-2EC Nil Nil Nil Nil Nil 
11. 1156 Nil Nil 2-3PC,Plenty Nil Nil 2-3PC,3-5EC Nil Nil Nil Nil Nil 
12. 1640 Nil Nil 1-2PC,0-1EC Nil Nil 1-3P,1-2EC Nil Nil Nil Nil Nil 
13.    1214 Nil Nil 1-2PC,2-4EC Nil Nil 1-2PC,1-2EC Nil Nil Nil Nil Nil 
14. 1607 Nil Nil 0-1PC,1-2EC Nil Nil 1-2PC,0-1EC Nil Nil Nil Nil Nil 
15. 1198 Nil Nil 1-2PC,1-2EC Nil Nil 2-5PC,4-5EC Nil Nil Nil Nil Nil 
16. 1152 Nil Nil 1-2PC,1-2EC Nil Nil 1-3PC,1-2EC Nil Nil Nil Nil Nil 
17. 1652 Nil Nil 1-3PC,2-4EC Nil Nil 1-3PC,2-5EC Nil Nil Nil Nil Nil 
18. 1176 Nil ++ 1-3PC,2-4EC Nil +++ 5-6PC,3-4EC  Nil Nil Nil Nil Nil 
19. 1231 Nil  Nil  0-1PC,1-2EC Nil  Nil  1-3PC,2-4EC Nil  Nil  Nil  Nil  Nil  
20. 1791 Nil Nil 2-4PC,2-5EC Nil Nil 3-5PC,1-2EC Nil Nil Nil Nil Nil 
 
 
          PC = Pus Cells   EC = Epithelial Cells 
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RADIOLOGICAL FINDINGS: 
 
S.NO OP.NO/IP.NO   Radiological findings – X - Ray MRI Cervical Spine 
1.  
1060 
 C4 – C5 block 
vertebra + Mild post. 
Disc bulge at C3 – C4 
+Disco – osteophytic 
protrusion C5 – C6 & 
C6 – C7 
2. 1515  Cervical Spondylosis 
+ R.Posterolateral 
disc protrusion C5 – 
C6 + narrowing of R 
neural foramina 
3. AL 6409 Cervical Spondylosis + large antero 
lateral osteophytes 
Dehydratic disc 
changes C3- C4, C4 – 
C5, C6 –C7 + 
Posterocentral disc 
bulge + 
B/Lnarrowing of 
neural foramen 
4. AJ 3676 Loss of lordosis + IV disc space 
narrowing 
 
5. AM3183 Loss of lordosis + IVF narrowing + 
osteophytic changes 
 
6. AI5144 Anteroposterior degenerative OA 
changes + IVD space maintained 
 
7. AL7832 IVD space narrowing + Loss of 
lordosis 
 
8. AM5387 Early Spondylosis + Prevertebral 
tissue normal 
Disc bulge at C5 – C6 
& C6 – C7 
9. AM3015 Cervical Sponylosis  
10. AM9512 Cervical Sponylosis + B/L 
rudimentary cervical rib 
Mild posterior disc 
bulge C3 – C4, C4 -C5 
& C5 – C6 
11. 1133 Loss of lordosis + B/L IVF 
narrowing + osteophytic changes 
 
12. 1640 Loss of lordosis + IVF narrowing + 
osteophytic changes 
 
13. 1621 IVD space narrowing + Loss of 
lordosis 
 
14. 1152 Osteophytic changes involved in C5 
– C6 & C6 – C7 
 
 
15. 1791 Cervical Spondylosis + Osteophytic 
changes 
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RESULTS AND OBSERVATIONS:   (OP CASES) 
 
 
 
 
C.R = Clinically Releived 
G.I  =  Good Improvement 
M.I  =  Moderate Improvement 
N.I  =  No Improvement 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
SI.NO 
 
O.P NO 
 
NAME 
 
AGE 
 
SEX 
 
DOA 
 
DOI 
 
DOD 
NO OF 
DAYS 
TREATED 
 
RESULT 
1. AL039 Venkatesan 50 M 2.8.08 2months 22.8.08 21 days G.I 
2. AI5794 Thara 50 F 7.8.08 6months 27.8.08 21days G.I 
3. AL6409 Jeyammal 60 F 9.8.08 2weeks 29.8.08 21days G.I 
4. AM3183 Janagi 60 F 25.8.08 2years 13.9.08 21days M.I 
5. AJ3676 Tamilselvi 34 F 25.8.08 2years 13.9.08 21days C.R 
6. AJ3454 Kumar 35 M 26.8.08 2years 14.9.08 21days NI 
7. AJ3692 Philips 39 M 28.8.08 1years 16.9.08 21days M.I 
8. AI5144 Balaji 35 M 6.9.08 5months 24.9.08 21days G.I 
9. AL7832 Manjula 36 F 8.9.08 2months 28.9.08 21days G.I 
10. AM5387 Balasubramanian 50 M 8.9.08 5months 28.9.08 21days G.I 
11. AM7162 Pazhaniyammal 29 F 9.9.08 5months 29.9.08 21days G.I 
12. AM7096 Daniel 45 M 9.9.08 5months 29.9.08 21days G.I 
13. AM9512 Pandiyarajan 32 M 18.9.08 1year 8.10.08 21days G.I 
14. AM8976 Sathyaveni 36 F 22.9.08 2months 12.10.08 21days C.R 
15. AG8071 Krishnamoorthi 60 M 24.9.08 1year 14.10.08 21days C.R 
16. AJ8019 Amudha 32 F 4.10.08 3months 24.10.08 21days G.I 
17. AN6125 Padmanoel 60 F 11.10.08 10years 31.10.08 21days G.I 
18. AN7073 Saraswathi 38 F 15.10.08 3months 4.11.08 21days G.I 
19. AO1510 Shanbagavalli 60 F 5.11.08 2years 25.11.08 21days M.I 
 20.                                                             AK2619 Mujipunisha 40 F 12.11.08 2months 2.12.08 21days G.I                                             
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RESULTS AND OBSERVATION:  (IP CASES) 
 
 
 
 
 
C.R = Clinically Releived 
G.I  =  Good Improvement 
M.I  =  Moderate Improvement 
N.I  =  No Improvement 
 
 
 
 
 
 
 
 
 
 
 
SI.NO 
 
IP.NO 
 
NAME 
 
AGE 
 
SEX 
 
DOA 
 
DOI 
 
DOD 
NO OF 
DAYS 
TREATD 
 
RESULT 
1. 1060 Vasanthi  54 F 31.7.08 2years 19.8.08 21 days G.I 
2. 1515 Sundaram 52 M 1.8.08 9months 23.8.08 21days G.I 
3. 1525 Balakrishnan 52 M 4.8.08 6months 23.8.08 21 days G.I 
4. 3015 Dhamodharan 53 M 27.8.08 20 days 13.9.08 21 days C.R 
5. 1127 Kalaivani 32 F 2.9.08 2months 28.9.08 21 days C.R 
6. 1133 Jeyalakshmi 50 F 4.9.08 10years 28.9.08 21 days NI 
7. 1140 Jamuna 40 F 6.9.08 2months 13.9.08 21 days G.I 
8. 1141 Selvi 52 F 6.9.08 3years 4.10.08 21 days G.I 
9. 1607 Shivaprakash 52 M 8.9.08 1year 23.9.08 21 days C.R 
10. 1614 Mani 49 M 9.9.08 5years 1.10.08 21 days G.I 
11. 1621 Anbazhagan 39 M 12.9.08 20 days 30.9.08 21 days G.I 
12. 1152 Sulochana 47 F 13.9.08 1year 10.10.8 21 days G.I 
13. 1156 Banu 41 F 15.9.08 3months 13.10.8 21 days G.I 
14. 1640 Elango 58 M 18.9.08 8months 22.10.8 21 days G.I 
15. 1652 Selvaraj 50 M 22.9.08 4years 18.10.8 21 days M.I 
16. 1176 Vaidegi 60 F 22.9.08 15 days 8.10.08 21 days G.I 
17. 1198 Loganayagi 48 F 3.10.08 2weeks 14.10.8 21 days G.I 
18. 1214 Rajeshwari 60 F 10.10.0
8 
10months 23.10.8 21 days G.I 
19. 1231 Kamala 46 F 23.10.0
8 
6months 23.1.08 21 days M.I 
20. 1791 Chellakannu 60 M 18.11.0
8 
6months 16.12.0
8 
21 days G.I 
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     DISCUSSION 
 
 
   The signs and symptoms of Kumbavatham can be correlated to those of Cervical 
Spondylosis.This study includes collection of data like age, sex, duration of the 
presenting signs and symptoms, precipitating factors that provoked the condition and 
radiological findings. 
 
The drugs used for this clinical trial are Vithurasa Mezhugu and Vatha Ennai.The 
detailed  
discussion of this dissertation topic by the author is based on the results and observations. 
 
Age distribution: 
 
  This study shows that the highest incidence of Kumbavatham is between 51 – 60 
years of age. 
 
Sex distribution: 
 
 The predominantly affected sex is female(57.5). The common cause for this may 
be  
calcium depletion around menopause. 
There is no significant difference between male and female on improvement 
(P>0.05) 
 
Living Lands (Thinai): 
 
 In this study all cases were from Neithal land. 
 Neithal land is known to be a promoter of Vatha diseases and hence higher 
incidence.              
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Gunam (Quality of the individual): 
 
 All the patients (100%) under study were predominantly of Rajogunam assessed 
from interrogation and other observations 
Socio – economic status: 
 
62.5% of cases of Kumbavatham belong to the middle class and 25%  to low 
socio economic status and 12.5 to high class. 
 
Seasonal distribution: 
 
 Kaarkaalam showed the highest incidence of 90% and 10% of cases were reported 
during Koothirkaalam. 
 
Precipitating factors: 
 
 Already the author has explained that ageing is the common cause for 
Kumbavatham. 
Apart from that, occupation takes the major part (50%) of the causative factor and 50% of 
cases with history of increased house hold works. (See Table No:18) 
 
Occupational references: 
 
 Those engaged in clerical work account for the highest number (32.5%) of cases. 
Maintaining the same posture throughout the working hours produces the impact. 
 
Clinical Manifestations: 
 
 Pain in the shoulder and upper limbs were present in all the 40 cases(100%). The 
other important features were stiffness (75%), headache(37.5%), numbness in upper 
limbs (57.5%), giddiness(46.7%), etc. 
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Derangement of Vaatham: 
 
 Viyaanan and  Samaanan were affected in all the 40 cases (100%) 
 
 
Derangement of Pittham: 
 
 Saathaga Pittham was affected in all the 40 cases (100%) 
 
Derangement of Kabam:  
 
 Santhigam was affected in all the 40 cases. 
 
Udal Thaathukkal: 
 
  Saaram was affected in the all 40 cases 
 Enbu was affected in all the 40 cases  
 
Gnanenthiriyam: 
 
 Among the 40 cases Kann was affected in 15 cases (25%) 
 
Kanmenthiriyam: 
 
 Among the 40 cases Kai was affected in40 cases (100%). Eruvaai was affected in  
5 cases (12.5%). 
 
 
Degree of Shoulder movements 
There is signifigant improvement in degree of shoulder movements after 
treatment (Table 21) 
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Eight parameters in our diagnostic system (Envagai Thervugal): 
 
In  Sparism, 52.5% showed tenderness. At the time of admission 5 patients 
12.5% reported to have constipation. 
 
In Moothiram, Neerkuri and Neikkuri were analysed. In 11 cases (18.3%) 
oil slowly spread, and in 29 patients (81.7%) oil spread like pearl (Kaba 
neer). 
 
Pulse reading was noted in all the 40 cases and vaathapitham was 
observed in all 
the  40 cases. 
 
 
Treatment: 
 
 The treatment was aimed at normalizing the deranged thodams and 
providing relief from symptoms. Before treatment the patients were advised to take 
Agasthiar kuzhambu – 130 mg  with hot water during early morning for purgation. The 
patient was advised to take rest without internal medicines and other activities on that 
day. 
 
    The author treated the patients with trial drugs Vithurasa Mezhugu (internal) – 
130 mg,bid with butter and Vaatha Ennai (external). During treatment, the patients were 
advised to follow paththiyam (avoid tamarind, tubers etc).  
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Sirappu Maruthuvam Techniques(methods) applied in Kumbavatham 
patients 
 
a) Thokkanam: 
  Among the 40 cases, 20 were treated additionally by Thokkanam with 
Vaatha Ennai once a day regularly.  
b) Exercises: 
All the 40 cases were instructed to do simple exercises for upper limbs  
 Curative Effect: 
  On the basis of curative effect of the trial drugs, all symptoms were 
relieved in 6 
patients (15%). Good improvement was assessed in 27 patients (67.5%). 
Moderate improvement was assessed in 5 patients (12.5%). No improvement was 
assessed in 2  
patients (5%). 
 
 No toxic and side effects were clinically observed in all cases 
  
 Qualitative analysis of drugs done in C.L.Baid Metha college of 
pharmacy, 
 Thoraippaakkam,   Chennai – 96, reveals Vithurasa Mezhugu contains 
Calcium, Iron(ferrous), Sulphate, Chloride, 
Phosphate,carbonate,Sugar,Alkaloids, Protein,Tannins, Phenols, 
Aminoacid, Glycosides, ,Flavonoids,Steroids,Starch, 
Tannic acid. 
 
 Pharmacological studies done in C.L.Baid Metha college of pharmacy, 
Thoraippaakkam,    Chennai – 96, reveals Vithurasa Mezhugu  exhibited 
significant analgesic, and anti-inflammatory activity in acute experimental 
inflammatory conditions in rats. 
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Toxicological studies of Vithurasa Mezhugu done in C.L.Baid Metha 
college of pharmacy, Thoraippaakkam,   Chennai – 96.  Acute oral 
toxicity study did notexhibit any mortality in rats.  
The repeated oral toxicity study conducted for15days with the drug did not  
exhibit significant changes in RBC count and in Hb%.However the test 
drug exhibited significant (P<0.001) alteration in liver marker enzymes 
levels (AST and ALT) 
 
Repeated oral toxicity study also exhibited reduction in body weight with 
dehydration. However, these alterations did not reflect on the 
histopathological study of liver tissue after 15 days repeated dosing. The 
duriug treatment also exhibited elevated levels of urea and uric acid levels. 
Cholesterol level also showed an upward trend after the treatment.  
 
However the histopathology of liver and kidney did not show any gross 
pathological changes in the tissues 
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SUMMARY 
 
 Based on Yugi Vaithiya Chinthamani, 40 cases of Kumbavatham were diagnosed  
Clinically. 20 cases were admitted and treated with the trial drugs in the inpatient ward 
and  
the rest of  the patients treated in the outpatient department of Sirappu Maruthuvam at  
the Ayothidoss Pandithar Hospital attached to National Institute of Siddha, Tambaram 
Sanatorium,  Chennai – 47. 
 
 The various Siddha methods of examination of the disease were carried out  
 and the data were recorded in the proforma. 
 
 The trial medicines selected for both internal and external treatment were 
 Vithurasa Mezhugu – 130 mg bid and Vatha Ennai – 30 ml respectively. 
  
 Before starting treatment careful history was taken and recorded for the 
 40 selected cases. 
 
 During treatment all the patients were put under patthiyam 
(a specific dietary regimen). 
 
Laboratory investigations were done periodically for all the cases before and after  
treatment. 
 
The observations made during the clinical study show that the internal 
drug Vithurasa Mezhugu and external application – Vatha Ennai are  
clinically effective. 
 
As per our Siddha Meteria Medica the ingredients of the trial medicines were 
found to have the property of controlling Vaatha diseases. 
 78
 
 
 
CONCLUSION 
 
 
 
The patients of Kumbavatham were treated with Vithurasa Mezhugu – 130 mg, twice 
a day with butter (internally) and Vatha Ennai (externally). The clinical evaluation 
of all the 40 cases of Kumbavatham under study has brought out the following 
results. 
 
 
  Clinically relieved              – 15% 
  Good improvement            -  67.5% 
  Moderate improvement      – 12.5% 
  No improvement                 – 5% 
 
 
 
 The results of the clinical trial indicate the efficacy of the drugs. However 
 there is recurrence of symptoms over months in some of the Kumbavatham  
 patients who engage themselves in the same occupation again or go back to 
their fast and  mechanical lifestyle. Most of the patients in whom the symptoms  
recurred were housewives who after their discharge from hospital continue  
to do their household works. 
 
Hence these drugs and methodology of the treatment will become one of the 
milestones in treating Kumbavatham successfully expecially in this era of  
fast and sophisticated lifestyle. 
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Preclinical pharmacological & Toxicological 
studies of Vithurasamezhugu for Analgesic, 
Antiinflammatory, antioxidant and   
antimicrobial  activities 
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1.0 MATERIALS AND METHODS 
 
 
1.1 Test Drugs 
 
 The following medicine used in the study was processed by the methods 
prescribed in standard text books of siddha medicine. 
 
Vithurasamezhugu (VRM) was prepared by the method prescribed in the text 
book of Sidha Medicine - Anuboga Vaithiya Navaneetham – Part 5. 
1.2 Preparation of drug for dosing 
 
 All drugs used for the study were suspended each time with 1% (w/v) solution of 
sodium carboxy methyl cellulose before administration. 
 
1.3 Drugs and chemicals 
 
Standard Drugs and fine chemicals used in these experiments were obtained from Sigma 
Chemicals company, U.S.A. Other analytical grade chemicals were obtained from S.d. 
Fine Chemicals Ltd., Mumbai. 
 
1.4 Experimental animals  
 
 Colony inbred animals strains of wistar rats of either sex weighing 200 - 250 g 
were used for the pharmacological and toxicological studies. The animals were kept 
under standard conditions 12:12 (day/night cycles) at 220C room temperature, in 
polypropylene cages. The animals were fed on standard pelleted diet (Hindustan Lever 
Pvt Ltd., Bangalore) and tap water ad libitum. The animals were housed for one week in 
polypropylene cages prior to the experiments to acclimatize to laboratory conditions. The 
experimental protocol was approved by the Institutional Animal Ethical Committee 
(IAEC). 
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1.5 Acute oral toxicity study     
 
Acute oral toxicity study was conducted as per the OECD guidelines 
(Organization of Economic Cooperation and Development) 423 (Acute Toxic Class 
Method). The acute toxic class method is a stepwise procedure with 3 animals of a single 
sex per step. Depending on the mortality and /or moribund status of the animals, on the 
average 2-4 steps may be necessary to allow judgment on the acute toxicity of the test 
substance. This procedure results in the use of a minimal number of animals while 
allowing for acceptable data based scientific conclusion. 
 
The method uses defined doses (5, 50, 300, 2000 mg/kg body weight) and the 
results allow a substance to be ranked and classified according to the Globally 
Harmonized System (GHS) for the classification of chemicals which cause acute toxicity 
 
Wistar albino rats of either sex weighing 200-250 g were fasted overnight, but 
allowed water ad libitum. Since the formulation is relatively non toxic in  clinical practice 
the highest dose of 2000 mg/kg/p.o (as per OECD guidelines “Unclassified”) was used in 
the acute toxicity study.   
 
The animals were observed closely for behavioral toxicity, if any by using FOB 
(Functional observation battery). 
 
 
1.6 Repeated oral toxicity study  
Repeated oral toxicity studies can be used to get additional information regarding 
the toxicity profile of a chemical. Repeated oral toxicity studies are defined as those 
studies where the chemical is administered to the animal for a period covering 
approximately 10% of the expected life of the animal. Usually, the dose levels are lower 
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than for acute studies and allow chemicals to accumulate in the body before lethality 
occurs, if the chemical possess this ability. 
 
 
Experimental procedure 
The following experimental procedure was followed to evaluate the repeated oral 
toxicity study of  VRM 
 
Group I : Control animals received 1%CMC, 2 ml/kg/p.o. for 15 days  
Group II : Vithurasamezhugu(VRM)(500mg/kg/po) was given in 1% sodium 
carboxy methyl cellulose solution for 15 days 
 Body weight, food intake and water intake was recorded at two intervals with 
simultaneous observation for toxic manifestation and mortality, if any. At the end of 
15days treatment all the animals were sacrificed by over dosage of ether anaesthesia. 
Blood was collected and used for haematological studies. Section of liver, kidney, and 
heart were dissected out and kept in 10% formalin for histopathological studies. 
1.7 Biochemical studies 
Aspartate aminotransferase (AST) 
 Aspartate aminotransferase was estimated using commercial AST kit (Span 
Diagnostics) by the method of Reitman and Frankel (1957). 
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Alanine aminotransferase (ALT) 
 Alanine aminotransferase was estimated using commercial AST kit (Span 
Diagnostics) by the method of Reitman and Frankel (1957). 
Alkaline phosphatase (ALP) 
 Alkaline phosphatase was assayed using commercial ALP kit (Span Diagnostics)  
by the method of King (1934). 
Urea,uric acid And cholesterol   
 Urea,uric acid and cholesterol were assayed using the commercial kit (Span 
Diagnostics) 
1.8 Haematological studies 
 
Erythrocyte count 
 Erythrocyte count was estimated by Hemocytometer method of Ghai (1995). 
Total Leukocyte Count (WBC) 
 Total Leukocyte Count was estimated by Hemocytometer method of John (1972). 
Haemoglobin  
 Haemoglobin was estimated by the method of Ghai (1995). 
1.9 Histopathological studies  
 Animals were sacrificed at the end of repeated oral toxicity study and tissues were 
processed for histopathological studies. 
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1.10 Analgesic, Antiinflammatory studies 
 
Analgesic activity   
Tail Flick method 
              Wistar rats of either sex(200-250g) were divided into different groups with 6 
animals in each group 
Group-1. Control animals received 1%CMC 10ml/Kg/po 
Group 2. Test drug at the dose of 500mg/kg/po 
 Withdrawal of tail (Tail Flick) for noxious thermal (radiant heat) can be used for 
screening drugs with analgesic activity. Radiant heat can be generated by passing 
electrical current through nichrome wire mounted in an analgesiometer. 
 The base of the tail of the test rats is placed on a nicrome wire. The tail 
withdrawal for the radiant heat (flicking response) is taken as the end point. Normally the 
rats and mice withdraw their tails within 3 – 5 secs. A cutoff time of 10 – 12 secs is used 
to prevent damage to the tail. Any animal failing to withdraw its tail in 3-5 secs is 
rejected from the study.  
 The reaction time of test drug, standard and control are taken at intervals of 30, 60 
and 120 mts. A reaction time (withdrawal time) increment of 2-5 secs more than the 
control animals can be considered for analgesic activity of the drug.  
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Anti inflammatory activity  
 Anti inflammatory activity was evaluated in acute model of inflammation. Wistar 
rats either sex weighing 200-250g were divided into different groups with 6 animals in 
each group 
Group-1. Control group received 15CMC 10ml/kg/po 
Group-2.  received Carrageenan (0.1% solution) and served as positive control 
Group-3  Received test drug(VRM) at the dose of 500mg/kg/po 
Group-4 received standard drug Diclofenac sodium(5mg/kg/po) 
Acute model 
Carrageenan induced hind paw edema  
 The carrageenan assay procedure was carried out according to the method of 
Wintar et al. (1962). Edema was induced by injecting 0.1 ml of 1% solution of 
carrageenan in saline into the plantar aponeurosis of the left hind paw of the rats.  The 
extracts, reference drug and the control vehicle (distilled water) were administered 60 
min prior to the injection of the carrageenan. The volumes of edema of the injected and 
contra lateral paws were measured at +1, 3 and 5 hrs after induction of inflammation 
using a plethysmometer (Bhatt et al., 1977) and percentage of anti-inflammatory activity 
was calculated.   
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1.11 In Vivo Antioxidant study 
 
Samples of serum collected from  rats treated with test drugs were assayed for 
GSH (Moron et al , 1979)  and LPO (Yagi, 1976)  and the results were compared with  
control group.  
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2.0 Results 
 
2.1 Preliminary basic, acidic radicals and phytochemical studies   
 
The qualitative chemical analysis and acidic, basic radicals assay of the drugs 
showed the presence of phytoconstituents and minerals as depicted in (Table 1). 
 
2.2 Acute oral toxicity study 
 
VRM at the dose of 2000mg/kg/po did not exhibit any mortality in rats. As per OECD 
423 guidelines the dose is said to be “Unclassified” under the toxicity scale. Hence 
further study with higher doses was not executed 
 
2.3 Repeated oral toxicity for 15 days 
 
Test drug VRM at the dose of 500 mg/kg/po when administered orally for 15 days 
in rats did not show toxicity in haematological parameters.. However the drug exhibited 
significant increase in the marker enzyme levels off liver and kidney.(Tables 2 and 3). 
15days repeated dosing of the drug exhibited elevation of serum cholesterol level(Table 
3).The body weights of the animals at the end of the study showed significant reduction 
in weight with dehydrarion. 
  
2.4 Histopathological study 
 
VRM  at the dose of 500 mg/kg/po daily administered for 15days did not show 
evidence of pathological lesions in the tissues tested (Plate 1). 
   
2.5 Analgesic, Antiinflammatory studies  
 
VRM at the dose of 500 mg/kg/p.o showed significant analgesic activity in rats 
(Table-4). VRM  also exhibited significant anti-inflammatory activity in carrageenan 
induced hind paw edema (acute inflammation model) in rats. The results of present study 
were comparable to that of the standard NSAID Diclofenac sodium (5 mg/kg/p.o) (Table-
5). 
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2.6 Antioxidant activity  
 
At the end of 15 days of repeated oral toxicity study when the plasma of drug 
treated animals was examined for GSH activity, the level of GSH activity was increased 
significantly (p>0.001) in test groups.  The LPO activity was significantly decreased in 
drug treated group when compared to control (Table 6). 
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   Discussion 
 
The Siddha formulation Vithurasa Mezhugu (VRM) was tested for its reverse 
pharmacological and toxicological profiles in the experimental rats. The drug did not 
exhibit mortality at the highest  dose of 2000 mg/kg/p.o. As per OECD 423 guidelines the 
dose is said to be “Unclassified” under the toxicity scale. Hence further study with higher 
doses was not executed 
 
The preliminary phytochemical study revealed the absence of alkaloids and steroids in 
the test drug. The test drug answered for  the presence of ca++, Fe++, sulphate, 
Chloride,phosphate and carbonate. 
 
The repeated oral toxicity study conducted for15days with the drug did not  
exhibit significant changes in RBC count and in Hb%. However the test drug exhibited 
significant (P<0.001) alteration in liver marker enzymes levels (AST and ALT) 
Repeated oral toxicity study also exhibited reduction in body weight with 
dehydration. However, these alterations did not reflect on the histopathological study of 
liver tissue after 15 days of repeated dosing. The duriug treatment also exhibited elevated 
levels of urea and uric acid levels. Cholesterol level also showed an upward trend after 
the treatment. However the histopathology of liver and kidney did not show any gross 
pathological changes in the tissues 
The drug exhibited significant analgesic and anti-inflammatory activity in acute 
experimental inflammatory conditions in rats... The analgesic activity was observed at the 
end of one hour and subsequently subsided to a non significant level at the end of two 
hours... A significant anti-inflammatory activity was obtained with the test drug in 
carrageenan induced hind paw edema model. The test drug showed maximum anti-
inflammatory activity at the end of 4th hour after carrageenan challenge. The result of test 
drug (500 mg/kg/p.o) was comparable to that of Diclofenac Sodium ( 5 mg/kg/p.o). Since 
the maximum anti-inflammatory activity (reduction in the paw edema volume) was 
observed at the end of 4th hour and the mechanism of anti-inflammatory activity of test 
drug may be attributed to its inhibitory activity on cyclooxygenase (COX) enzymes. 
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The drug treatment for 15days increased the antioxidant status of GSH with a 
decrease in LPO in serum of treated rats when compared to controls. Both these 
parameters observed in this study are indicative of antioxidant property of the drug. 
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Table-1 
Preliminary acid, basic radicals and phytochemical screening of Vithurasa 
mezhugu(VRM) 
S.No. Constituents VRM 
1. Calcium + 
2. Iron (Ferric) - 
3. Iron (Ferrous) + 
4. Sulphate + 
5. Chloride + 
6. Carbonate  + 
7. Starch + 
8. Phosphate + 
9. Tannic acid + 
10. Unsaturated + 
11. Sugar + 
12. Alkaloids + 
13. Steroids + 
14. Protein + 
15. Tannins + 
16. Phenols + 
17. Flavanoids + 
18. Saponins - 
19. Amino acid + 
20. Glycosides + 
 
(+) - present 
(-) -Absent 
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Table 2 
 
 
Effect of Siddha Formulations(VRM) on Haematological parameters after 15 days 
repeated oral dosing (500 mg/kg) 
 
 
Differential leucocyte count (%) Groups Hb 
(gm/dl) 
RBC 
(millions/cu.
mm) 
WBC 
(cells/cu.mm) Lympho 
cytes 
Mono 
cytes 
Granulo 
cytes 
Normal 14.00.  
± 0.34 
6.08 ± 0.35 ns 6400± 491.44 76.06 ± 3.89 
ns
 
5.30 ± 1.04 16.50 ±  
4.27 
VRM 
(500mg/
kg. p.o.,)  
13.50 ± 
0.60ns 
5.81 ± 0.70 ns 6586.66 ± 
3.323ns 
74.67 ± 3.32 
ns
 
8.16 ± 1.7 
ns
  
18.66 ± 3.44 
ns
 
 
N=6; Values are expressed as mean ± S.D followed by Students Paired ‘T’ Test 
Ns – non significant when compared to control groups  
 
 
 
 
Table 3 
 
Effect of Siddha formulation (VRM) on Biochemical markers of liver and kidney 
after 15 days of repeated oral dosing (500 mg/kg/po) in rats  
 
 
Groups AST  
(IU/L) 
ALT  
(IU/L) 
Cholesterol 
(mg/dl) 
Urea 
(mg/100ml) 
Uric acid 
(mg/dl) 
Normal 77.48±0.23  26.70 ± 0.81 45.06 ± 0.89 24.86 ± 0.37 1.86 ± 0.64 
VRM 
(500mg/kg. p.o.,) 
96.55±5.92 *** 40.13 ± 2.67 
***
 
29.66 ± 0.68*** 49.60 ± 0.69 
***
 
2.49 ± 0.28*** 
 
 
N=6; Values are expressed as mean ± S.D followed by Students Paired ‘T’ Test 
Ns – non significant when compared to control groups, 
***P<0.001 as compared with control  
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Table 4 
 
Analgesic activity of (VRM) using Tail flick  Method 
 
 
Paw licking response  (Sec) 
 
Groups 
0 min 
( Sec) 
30 min 
( Sec ) 
60 min 
(Sec ) 
120 min 
(Sec) 
Control 2.266± 0.396 2.393± 0.96 2.46±0.367 2.532± 0.653 
 
VRM 
(500mg/kg. 
p.o.,) 
2.811 ±  0.361 
 
4.807 ± 0.450 
*** 
5.621± 0.077 
*** 
2.762± 1.213 
 
 
n=6,  Values are expressed as mean ± S.D using followed by paired T – test  
***P<0.001 as compared with control.  
 
                                                      
 
 
                                                          Table 5 
 
Anti inflammatory activity of  VRM in carrageenan induced hind paw edema in rats 
 
Paw volume ( ml) by mercury Displacement at regular interval of 
time 
 
Groups 
0min 30min 60min 120min 240min 4th hrs 
Control 
 
 
1.583 ± 
0.1915 
1.766 ± 
0.1366 
2.0 ± 
5.164 
2.195 ± 
7.7619 
2.25 ± 
0.136 
2.43 ± 
0.4612 
VRM  
(500mg/kg. 
p.o.,) 
1.686 ± 
0.1402  
ns 
1.828 ± 
0.1397 
ns 
2.1 ± 
0.304 
ns 
2.65 ± 
0.022 
ns 
2.97 ± 
0.1266 
ns 
1.43 ± 
0.1033 
*** 
Standard 
(Dic.Sodium 
5 mg/kg/po) 
0.835 ± 
0.065 ns 
1.315 ± 
0.069** 
1.128 ± 
0.049** 
1.011 ± 
0.056** 
0.896 ± 
0.048** 
0. 85 ± 
0.054 
 
n=6; Values are expressed as mean ± S.D followed by paired T – test . 
ns - Non significant as compared with control; 
P< 0.001 (***),P <0.003(**)as compared with control. 
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Table 6 
 
 
Anti oxidant activity of Siddha Formulation (VRM)  
after 15 days repeated oral dosing (500 mg/kg) 
 
 
Groups LPO 
umol/gram proteins 
GSH 
Umol/gram protein 
Control 0.68 ± 1.37 37.48 ± 2.31 
 
VRM (500mg/kg. 
p.o.,) 
0.46 ± 4.90*** 57.51 ± 0.35*** 
 
 
N=6; Values are expressed as mean ± S.D followed by Student T- Test. 
***P<0.001 as compared with control.  
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NATIONAL INSTITUTE OF SIDDHA 
AYODHIDOSS PANDIDHAR HOSPITAL, CHENNAI – 47. 
POST GRADUATE DEPARTMENT OF SIRAPPU MARUTHUVAM 
     AN OPEN TRIAL OF ‘VITHU RASA MEZHUGU’ AND ‘VATHA ENNAI’ 
FOR THE TREATMENT OF  
“KUMBA VATHAM (CERVICAL SPONDYLOSIS)” 
 
FORM I - SELECTION PROFORMA/CASE SHEET 
 
1. OP/ IP No:                                                 2. BED No:                           3. Sl. No:  
 4.   NAME:                                                      5. AGE:                                 6. GENDER:  
 7.   OCCUPATION:                                        8. SOCIAL STATUS 
9.  DATE OF ADMISSION:                          10. DATE OF DISCHARGE: 
11. POSTAL ADDRESS: 
 
12. COMPLAINTS & DURATION:    
  
 
 
13. HISTORY OF PRESENT ILLNESS:  
 
 
14. PAST HISTORY:  
   
15. FAMILY HISTORY: 
Lecturer                         HOD 
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16. MENSTRUAL HISTORY (If applicable):  
17. HABITS:  
                                                             Yes            No                                                                                                                                                                  
1. Smoker 
2. Alcoholic 
3. Betel nut chewer 
4. Non-Vegetarian/Vegetarian      
5. Drug addiction                                 
18. GENERAL EXAMINATION: 
1. Body weight [Kg]         :                      
2. Height [cm]                      :                        
3. Body Temperature [F]      :   
4. Blood Pressure (mmHg) :      
5. Pulse Rate /min. : 
6. Heart Rate / min.  : 
7. Respiratory Rate /min. :   
                                                             Yes             No   
8. Pallor : 
9. Jaundice :   
10. Clubbing : 
11. Cyanosis : 
12. Pedal Oedema : 
13. Lymphadenopathy    :                                        
14. Jugular venous pulsation :   
19. CLINICAL EXAMINATION: 
I. INSPECTION: 
     1. Attitude: Normal                Affected                                                                                      
Present      Absent 
        2. Muscular spasm     …………………………… 
        3. Muscle wasting of the upper limbs   …………………………… 
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II. PALPATION: 
 Present            Absent 
    1. Tenderness    
 ………………………………. 
    2. Muscle spasm    
 ……………………………….  
    3. Muscle wasting    
 ………………………………. 
III. MOVEMENTS:  
Restriction of Movements       Neck:          Full          Partial              No 
                                                   Shoulder:    Full          Partial                    No 
1. NECK:   PAIN  MUSCULAR SPASM      ROM 
                                                                  Yes   No             Yes   No            Normal   Reduced 
i. Rotation 
ii. Flexion  
iii. Extension 
            iv. Lateral bending 
                (Dorsal cervical region) 
            v. Nodding (Atlanto-occipitalis)  
2. SHOULDER:                            PAIN      MUSCULAR SPASM             ROM 
                                                               Yes      No              Yes    No                Normal     
Reduced 
i. Flexion 
ii. Extension 
iii. Internal rotation 
iv. External rotation 
v. Abduction 
vi. Adduction 
3. SHOULDER MOVEMENTS: 
 (Degree of movements)         Before treatment                       After treatment 
IV. NEUROLOGICAL EXAMINATION: 
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i.  Sensation  Normal                        Abnormal                 
…………. 
ii. Tone                            Normal  Abnormal                 
…………. 
iii.  Power                                            Normal                       Abnormal                 
………….. 
iv. Muscle wasting  Present              Absent                      
………….. 
V. AUTONOMIC NERVOUS SYSTEM     Normal Affected 
      i. Bladder     
      ii. Bowel 
VI. REFLEXES: 
1. DEEP TENDON REFLEXES     Normal       Diminished    Exaggerated 
        i. Biceps 
        ii. Triceps 
        iii. Supinator 
        iv. Knee jerk 
        v. Ankle jerk 
2. SUPERFICIAL TENDON REFLEXES:   
i. Abdominal                          Present                      Absent 
ii. Cremasteric                       Present                      Absent 
iii. Plantar Flexion      Extension 
3. CLONUS        Present           Absent 
          i. Ankle 
          ii. Petallar                  
20. CLINICAL ASSESSMENT: 
I. PAIN: 
A. Pain in the Nape:      No                    Mild                  Moderate                Severe  
         i. Onset              Sudden                          Gradual              
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         ii. Nature:           Local                             Diffuse           Others 
B. Pain in the shoulder: 
            Right                  Left                  Both 
C. Pain in the upper limb(s): 
            Right                  Left                  Both 
D. Nature of pain       Shooting          Burning  Others …………………        
    Yes        No 
E. Aggravating factor         - Movements 
F. Relieving factor              - Rest  
 Yes   No  
II. Numbness 
III. Tenderness        
IV. Giddiness 
V. Headache               
VI. Stiffness             
VII. Burning sensation of the eyes 
VIII. Burning sensation of the tongue 
IX. Pain below the umbilicus 
21. EXAMINATION OF OTHER SYSTEMS: 
     Normal      Abnormal 
1.  CVS  
2.  RS    
3.  CNS 
4. ABDOMEN   
5.  GENITO-URINARY                                                     
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SIDDHA ASPECTS 
1 . NILAM: 
       1. Kurinji               2. Mullai           3. Marutham          4. Neithal         5. Paalai 
2 . KAALAM: 
         1. Kaar Kaalam             2. Koothir Kaalam        3. Munpani Kaalam      
         4. Pinpani Kaalam          5. Ilavenir Kaalam        6. Muduvenir Kaalam 
3. YAAKKAI: 
 1. Vatham      2. Pitham      3. Kabam     
4. Vathapitham  5. Pithavatham    6. Kabavatham       
7. Vathakabam    8. Pithakabam     9. Kabapitham    
4. GUNAM: 
 1. Sathuvam  2. Rasatham             3. Thamasam 
5. IYMPORIGAL: 
      Normal Affected   
1. Mei                                           ………………………………………….. 
2. Vaai                                          …………………………………………... 
3. Kan                                           …………………………………………… 
4. Mookku                                    …………………………………………… 
5. Sevi                                           …………………………………………… 
6. KANMENDHIRIUM / KANMAVIDAYAM: 
   Normal   Affected    
1. Kai                                            …………………………………………... 
2. Kaal                                          …………………………………………... 
3. Vaai                                           ………………………………………….. 
4. Eruvaai                                      ………………………………………….. 
5. Karuvaai                                    ………………………………………….. 
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7. UYIR THATHUKKAL: 
I. VATHAM:     Normal    Affected 
1. Piraanan                                        ………………………………………… 
2. Abaanan                                       …………………………………………    
3. Viyaanan                                      …………………………………………            
4. Uthaanan                                      …………………………………………      
5. Samaanan                                     ………………………………………….                              
6. Naagan                                         ………………………………………….    
7. Koorman                                    ………………………………………….  
8. Kirukaran                                   …………………………………………         
9. Devathathan                               …………………………………………     
10. Dhananjeyan                            …………………………………………  
II. PITHAM :                Normal    Affected 
1. Analam                                     ………………………………………….         
2. Ranjagam                                  ………………………………………….   
3. Saathagam                                  …………………………………………..       
4. Aalosagam                                  ………………………………………….           
5. Praasagam                                   …………………………………………. 
III. KABAM:                Normal    Affected 
 1. Avalambagam                          …………………………………………… 
2. Kilethagam                              …………………………………………… 
3. Pothagam                                 …………………………………………… 
4. Tharpagam                               ……………………………….…………... 
5. Santhigam                                …………………………………………… 
8. UDAL THAATHUKKAL:    Normal   Affected 
 1. Saaram                                                   ………………………………….. 
2. Senneer                                           ………………………………….. 
3. Oon                                                        ………………………………….. 
4. Kozhuppu                                            ………………………………….. 
5. Enbu                                                      …………………………………... 
6. Moolai                                                   .………………………………….. 
7. Sukkilam / Suronitham                          …………………………………... 
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9. ENVAGAI THERVUGAL: 
 1 . Naadi    ……………………………………………………. 
                                 Normal    Affected 
2. Sparisam                         …………………………….. 
3. Naa                                       …………………………….. 
4. Niram                                          …………………………….. 
5. Mozhi                                           …………………………….. 
6. Vizhi                                             …………………………….. 
7. Malam 
                                        Normal  Affected 
      a. Niram                  …………………………….. 
      b. Nurai                   …………………………….. 
      c. Kirumi                 .…………………………….. 
      d. Thanmai:                
                                  i. Irugal                          ii. Ilagal                             
8. Moothiram: 
    I. NEERKURI:  
                                     Normal    Affected 
     a. Niram                     …………………………….. 
     b . Manam                    …        …………………………….. 
     c. Edai                         …………………………….. 
     d. Nurai          …………………………….. 
     e. Enjal                                     …………………………….. 
   II. NEIKURI: ………………………………………. 
                  Vatha Neer             Pitha Neer            Kaba Neer 
 105 
10. LABORATORY INVESTIGATIONS: 
 
I. BLOOD: 
 
                                 TC (Cells/Cumm):          
         DC (%):  N            L          M             E                      
         ESR (mm) :  ½ hr                           1 hr 
         Hb (gm%)      
         Blood Sugar (mg %): 
             Fasting       Post Prandial                   
                Serum Creatinine (mg %):  
                Blood urea (mg %): 
                Blood cholesterol (mg %): 
     II. URINE: 
                                      
Albumin:                                                    
Sugar:                                                           
Deposits:      
              Epithelial cells:                           
        Pus cells:                       
        Red blood cells:                   
Casts/Crystals:        
      III. MOTION:    
Ova  - 
Cyst  - 
Occult blood - 
Pus cells - 
X – RAY CERVICAL SPINE: 
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NATIONAL INSTITUTE OF SIDDHA 
TAMBARAM SANATORIUM, CHENNAI-47 
DEPARMENT OF SIRAPPU MARUTHUVAM 
AN OPEN TRIAL OF VITHU RASA MEZHUGU AND VATHA ENNAI FOR THE 
TREATMENT OF KUMBA VATHAM (CERVICAL SPONDYLOSIS) 
FORM II - CLINICAL ASSESSMENT 
1. OP/ IP No          2. BED No                          3. Sl. No                       
4. NAME                                    5. AGE            6. GENDER 
7. DATE OF ADMISSION                                       8. DATE OF DISCHARGE                   
I. INSPECTION: 
1. Attitude: Normal                Affected                                                                
Present      Absent 
        2. Muscular spasm     …………………………… 
        3. Muscle wasting of the upper limbs   …………………………… 
II. PALPATION: 
 Present            Absent 
    1. Tenderness                                 ……………………………. 
    2. Muscle spasm           ……………………………….  
    3. Muscle wasting           ………………………………. 
III. MOVEMENTS:  
Restriction of Movements       Neck:          Full          Partial              No 
                                                   Shoulder:    Full          Partial                    No 
1. NECK:   PAIN  MUSCULAR SPASM      ROM 
                                                                  Yes   No             Yes   No            Normal   Reduced 
i. Rotation 
ii. Flexion  
iii. Extension 
            iv. Lateral bending 
                (Dorsal cervical region) 
            v. Nodding (Atlanto-occipitalis)  
 107 
2. SHOULDER:                           PAIN          MUSCULAR SPASM           ROM 
                                                               Yes      No              Yes    No                Normal   Reduced 
i. Flexion 
ii. Extension 
iii. Internal rotation 
iv. External rotation 
v. Abduction 
vi. Adduction 
3. SHOULDER MOVEMENTS: 
 (Degree of movements)         Before treatment                       After treatment 
IV. NEUROLOGICAL EXAMINATION: 
i.  Sensation  Normal                        Abnormal              …………. 
ii. Tone                            Normal  Abnormal              …………. 
iii.  Power                                            Normal                       Abnormal              ………….. 
iv. Muscle wasting  Present              Absent                   ………….. 
V. AUTONOMIC NERVOUS SYSTEM     Normal Affected 
      i. Bladder     
      ii. Bowel 
VI. REFLEXES: 
1. DEEP TENDON REFLEXES     Normal       Diminished    Exaggerated 
        i. Biceps 
        ii. Triceps 
        iii. Supinator 
        iv. Knee jerk 
        v. Ankle jerk 
2. SUPERFICIAL TENDON REFLEXES:   
i. Abdominal                          Present                      Absent 
ii. Cremasteric                       Present                      Absent 
iii. Plantar Flexion      Extension 
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3. CLONUS        Present           Absent 
          i. Ankle 
          ii. Petallar                  
LAB INVESTIGATIONS CHART 
DATE OF 
ADMISSION 10
th
  DAY DATE OF DISCHARGE 
 
I. BLOOD: 
                                 TC (Cells/Cumm):          
         DC (%):      
         ESR (mm) :  ½ hr  &   1 hr 
         Hb (gm%):      
         Blood Sugar (mg %): 
                       Fasting:   
                       Postprandial:                 
                Serum Creatinine (mg %):
        Blood urea (mg %): 
          Blood cholesterol (mg %):  
   
     II. URINE : 
Albumin :                                                   
Sugar :                                       
Deposits :   
             Epithelial cells:                  
       Pus cells:                
       Red blood cells:  
                   Casts/Crystals:  
   
     III. MOTION:   
Ova   
Cyst   
Occult blood  
Pus cells  
   
     IV. X-RAY CERVICAL SPINE:    
Lecturer                   HOD 
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NATIONAL INSTITUTE OF SIDDHA, CHENNAI-47. 
DEPARTMENT OF SIRAPPU MARUTHUVAM 
AN OPEN CLINICAL TRIAL OF ‘VITHU RASA MEZHUGU’ AND ‘VATHA ENNAI’ 
FOR THE TREATMENT OF ‘KUMBA VATHAM (CERVICAL SPONDYLOSIS)’. 
 
 
 
CERTIFICATE BY INVESTIGATOR 
 
I certify that I have disclosed all details about the study in the terms readily understood 
by the patient. 
 
                                                                            Signature…………………. 
 
Date………                                                                           Name…………………… 
 
    CONSENT BY PATIENT 
 
I have been informed to my satisfaction, by the attending physician, the purpose 
of the clinical trial, and the nature of drug treatment and follow-up including the 
laboratory investigations to be performed to monitor and safeguard my body functions. 
 I am aware of my right to opt out of the trial at any time during the course of the 
trial without having to give the reasons for doing so. 
 I, exercising my free power of choice, hereby give my consent to be included as a 
subject in the clinical trial of ‘Vithu Rasa Mezhugu’ and ‘Vatha Ennai’ for the 
management of ‘Kumba Vatham (CERVICAL SPONDYLOSIS)’. 
                              Signature……………………. 
 
Date………                                                                 Name………………………… 
 
 
          Signature of witness…………. 
 
CONSENT FORM 
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Date………                                                                  Name………………………… 
 
                      Relationship…………………. 
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